CHEBI ONTOLOGY - ANNOTATIONS |
|
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
|
Term: | glycerolipid |
|
Accession: | CHEBI:35741
|
browse the term
|
Definition: | Any member of the group of lipids containing a common glycerol backbone to which at least one fatty acid-derived group is attached. |
Synonyms: | related_synonym: | glycerolipids |
| xref: | PMID:18606873 |
|
|
|
G |
Abca1 |
ATP binding cassette subfamily A member 1 |
decreases expression |
ISO |
trilinolenin results in decreased expression of ABCA1 mRNA |
CTD |
PMID:18356535 |
|
NCBI chr 5:67,678,267...67,801,162
Ensembl chr 5:67,681,297...67,801,170
|
|
G |
Abcg5 |
ATP binding cassette subfamily G member 5 |
decreases expression |
ISO |
trilinolenin results in decreased expression of ABCG5 mRNA |
CTD |
PMID:18356535 |
|
NCBI chr 6:9,965,118...9,990,563
Ensembl chr 6:9,965,118...9,990,563
|
|
G |
Abcg8 |
ATP binding cassette subfamily G member 8 |
decreases expression |
ISO |
trilinolenin results in decreased expression of ABCG8 mRNA |
CTD |
PMID:18356535 |
|
NCBI chr 6:9,945,629...9,964,912
Ensembl chr 6:9,945,629...9,964,912
|
|
G |
Cyp27a1 |
cytochrome P450, family 27, subfamily a, polypeptide 1 |
decreases expression |
ISO |
trilinolenin results in decreased expression of CYP27A1 mRNA |
CTD |
PMID:18356535 |
|
NCBI chr 9:76,264,655...76,294,551
Ensembl chr 9:76,264,860...76,294,551
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
increases expression |
ISO |
trilinolenin results in increased expression of HMGCR mRNA |
CTD |
PMID:18356535 |
|
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
|
|
G |
Mttp |
microsomal triglyceride transfer protein |
increases expression |
ISO |
trilinolenin results in increased expression of MTTP mRNA |
CTD |
PMID:18356535 |
|
NCBI chr 2:226,613,090...226,654,239
Ensembl chr 2:226,613,090...226,654,239
|
|
G |
Npc1l1 |
NPC1 like intracellular cholesterol transporter 1 |
decreases expression |
ISO |
trilinolenin results in decreased expression of NPC1L1 mRNA |
CTD |
PMID:18356535 |
|
NCBI chr14:81,071,448...81,091,113
Ensembl chr14:81,071,451...81,091,113
|
|
G |
Scd |
stearoyl-CoA desaturase |
decreases expression |
ISO |
trilinolenin results in decreased expression of SCD1 mRNA |
CTD |
PMID:8729090 |
|
NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562
|
|
|
G |
Abca1 |
ATP binding cassette subfamily A member 1 |
decreases expression |
ISO |
trilinolein results in decreased expression of ABCA1 mRNA |
CTD |
PMID:18356535 |
|
NCBI chr 5:67,678,267...67,801,162
Ensembl chr 5:67,681,297...67,801,170
|
|
G |
Abcg5 |
ATP binding cassette subfamily G member 5 |
decreases expression |
ISO |
trilinolein results in decreased expression of ABCG5 mRNA |
CTD |
PMID:18356535 |
|
NCBI chr 6:9,965,118...9,990,563
Ensembl chr 6:9,965,118...9,990,563
|
|
G |
Abcg8 |
ATP binding cassette subfamily G member 8 |
decreases expression |
ISO |
trilinolein results in decreased expression of ABCG8 mRNA |
CTD |
PMID:18356535 |
|
NCBI chr 6:9,945,629...9,964,912
Ensembl chr 6:9,945,629...9,964,912
|
|
G |
Cyp27a1 |
cytochrome P450, family 27, subfamily a, polypeptide 1 |
decreases expression |
ISO |
trilinolein results in decreased expression of CYP27A1 mRNA |
CTD |
PMID:18356535 |
|
NCBI chr 9:76,264,655...76,294,551
Ensembl chr 9:76,264,860...76,294,551
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
increases expression |
ISO |
trilinolein results in increased expression of HMGCR mRNA |
CTD |
PMID:18356535 |
|
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
|
|
G |
Mttp |
microsomal triglyceride transfer protein |
increases expression |
ISO |
trilinolein results in increased expression of MTTP mRNA |
CTD |
PMID:18356535 |
|
NCBI chr 2:226,613,090...226,654,239
Ensembl chr 2:226,613,090...226,654,239
|
|
G |
Npc1l1 |
NPC1 like intracellular cholesterol transporter 1 |
decreases expression |
ISO |
trilinolein results in decreased expression of NPC1L1 mRNA |
CTD |
PMID:18356535 |
|
NCBI chr14:81,071,448...81,091,113
Ensembl chr14:81,071,451...81,091,113
|
|
G |
Scd |
stearoyl-CoA desaturase |
multiple interactions decreases expression |
ISO |
Clofibrate inhibits the reaction [trilinolein results in decreased expression of SCD1 mRNA] |
CTD |
PMID:8790349 |
|
NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562
|
|
|
G |
Il4 |
interleukin 4 |
multiple interactions |
ISO |
[dibutyrylglycerol analog co-treated with Fluorescein-5-isothiocyanate] affects the secretion of IL4 protein |
CTD |
PMID:29198882 |
|
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
|
|
G |
Trpa1 |
transient receptor potential cation channel, subfamily A, member 1 |
increases activity |
ISO |
dibutyrylglycerol analog results in increased activity of TRPA1 protein |
CTD |
PMID:29198882 |
|
NCBI chr 5:4,379,862...4,434,133
Ensembl chr 5:4,379,999...4,433,570
|
|
|
G |
Pnlip |
pancreatic lipase |
increases metabolic processing |
ISO |
PNLIP protein results in increased metabolism of 1,2-didecanoylglycerol |
CTD |
PMID:9822688 |
|
NCBI chr 1:257,774,012...257,811,656
Ensembl chr 1:257,798,581...257,811,654
|
|
G |
Pnliprp2 |
pancreatic lipase related protein 2 |
increases metabolic processing |
EXP |
PNLIPRP2 protein results in increased metabolism of 1,2-didecanoylglycerol |
CTD |
PMID:9822688 |
|
NCBI chr 1:257,897,766...257,916,434
Ensembl chr 1:257,897,766...257,916,434
|
|
G |
Sprr1a |
small proline-rich protein 1A |
increases expression |
ISO |
1,2-didecanoylglycerol results in increased expression of SPRR1A protein |
CTD |
PMID:8617999 |
|
NCBI chr 2:178,055,096...178,057,012
Ensembl chr 2:178,055,096...178,057,063
|
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
ISO |
1,2-Dipalmitoylphosphatidylcholine inhibits the reaction [Asbestos, Crocidolite results in increased secretion of IL6 protein] |
CTD |
PMID:19041333 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Prnp |
prion protein |
multiple interactions affects folding |
ISO |
Copper affects the reaction [1,2-Dipalmitoylphosphatidylcholine affects the folding of PRNP protein modified form] |
CTD |
PMID:20936829 |
|
NCBI chr 3:119,186,073...119,201,513
Ensembl chr 3:119,177,485...119,203,937
|
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
increases expression |
ISO |
dioctanoylphosphatidic acid results in increased expression of PTGS2 protein |
CTD |
PMID:11854442 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
|
G |
Fech |
ferrochelatase |
affects abundance |
ISO |
FECH protein affects the abundance of 1-palmitoyl-2-docosahexaenoyl-sn-glycero-3-phosphocholine |
CTD |
PMID:29906468 |
|
NCBI chr18:57,945,123...57,978,327
Ensembl chr18:57,945,122...57,979,348
|
|
|
G |
Fech |
ferrochelatase |
affects abundance |
ISO |
FECH protein affects the abundance of 1-palmitoyl-2-linoleoylphosphatidylcholine |
CTD |
PMID:29906468 |
|
NCBI chr18:57,945,123...57,978,327
Ensembl chr18:57,945,122...57,979,348
|
|
|
G |
Iyd |
iodotyrosine deiodinase |
multiple interactions |
ISO |
1-monomyristin inhibits the reaction [IYD protein results in increased metabolism of Monoiodotyrosine] |
CTD |
PMID:33352258 |
|
NCBI chr 1:40,003,999...40,019,323
Ensembl chr 1:40,004,041...40,019,319
|
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
increases phosphorylation |
ISO |
palmitoyl glycerol results in increased phosphorylation of AKT1 protein |
CTD |
PMID:37466199 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Birc2 |
baculoviral IAP repeat-containing 2 |
decreases expression |
ISO |
palmitoyl glycerol results in decreased expression of BIRC2 protein |
CTD |
PMID:37466199 |
|
NCBI chr 8:4,968,856...4,989,325
Ensembl chr 8:4,968,842...4,988,732
|
|
G |
Birc3 |
baculoviral IAP repeat-containing 3 |
decreases expression |
ISO |
palmitoyl glycerol results in decreased expression of BIRC3 protein |
CTD |
PMID:37466199 |
|
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
decreases expression |
ISO |
palmitoyl glycerol results in decreased expression of BIRC5 protein |
CTD |
PMID:37466199 |
|
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
ISO |
palmitoyl glycerol results in decreased expression of and results in increased cleavage of CASP3 protein |
CTD |
PMID:37466199 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Ccnd1 |
cyclin D1 |
decreases expression |
ISO |
palmitoyl glycerol results in decreased expression of CCND1 protein |
CTD |
PMID:37466199 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
increases expression |
ISO |
palmitoyl glycerol results in increased expression of CDKN1A protein |
CTD |
PMID:37466199 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Map1lc3b |
microtubule-associated protein 1 light chain 3 beta |
increases lipidation multiple interactions |
ISO |
palmitoyl glycerol results in increased lipidation of MAP1LC3B protein Chloroquine promotes the reaction [palmitoyl glycerol results in increased lipidation of MAP1LC3B protein] |
CTD |
PMID:37466199 |
|
NCBI chr19:49,665,795...49,673,655
Ensembl chr19:49,665,791...49,677,690
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
multiple interactions |
ISO |
palmitoyl glycerol results in decreased expression of and results in increased cleavage of PARP1 protein |
CTD |
PMID:37466199 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pik3r1 |
phosphoinositide-3-kinase regulatory subunit 1 |
affects phosphorylation |
ISO |
palmitoyl glycerol affects the phosphorylation of PIK3R1 protein |
CTD |
PMID:37466199 |
|
NCBI chr 2:32,878,942...32,963,668
Ensembl chr 2:32,882,032...32,963,631
|
|
G |
Ripk1 |
receptor interacting serine/threonine kinase 1 |
decreases expression |
ISO |
palmitoyl glycerol results in decreased expression of RIPK1 protein |
CTD |
PMID:37466199 |
|
NCBI chr17:30,839,639...30,871,824
Ensembl chr17:30,839,650...30,871,824
|
|
G |
Ripk3 |
receptor-interacting serine-threonine kinase 3 |
decreases expression |
ISO |
palmitoyl glycerol results in decreased expression of RIPK3 protein |
CTD |
PMID:37466199 |
|
NCBI chr15:29,283,153...29,292,107
Ensembl chr15:29,283,145...29,292,121
|
|
G |
Sqstm1 |
sequestosome 1 |
decreases expression |
ISO |
palmitoyl glycerol results in decreased expression of SQSTM1 protein |
CTD |
PMID:37466199 |
|
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
|
|
G |
Xiap |
X-linked inhibitor of apoptosis |
decreases expression |
ISO |
palmitoyl glycerol results in decreased expression of XIAP protein |
CTD |
PMID:37466199 |
|
NCBI chr X:120,890,537...120,938,413
Ensembl chr X:120,897,907...120,934,700
|
|
|
G |
Nr5a2 |
nuclear receptor subfamily 5, group A, member 2 |
multiple interactions |
ISO |
[NR5A2 gene mutant form results in increased susceptibility to Dietary Fats] which results in increased abundance of 1-oleoyl lysophosphatidylcholine |
CTD |
PMID:29515023 |
|
NCBI chr13:48,313,634...48,433,494
Ensembl chr13:48,316,301...48,433,326
|
|
G |
Smad3 |
SMAD family member 3 |
decreases abundance |
ISO |
SMAD3 protein results in decreased abundance of 1-oleoyl lysophosphatidylcholine |
CTD |
PMID:23034213 |
|
NCBI chr 8:64,126,829...64,236,960
Ensembl chr 8:64,110,039...64,236,960
|
|
|
G |
Agtr1a |
angiotensin II receptor, type 1a |
increases expression |
ISO |
1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine results in increased expression of AGTR1 mRNA |
CTD |
PMID:16386258 |
|
NCBI chr17:34,173,446...34,226,892
Ensembl chr17:34,174,429...34,226,946
|
|
G |
Alox5 |
arachidonate 5-lipoxygenase |
increases expression |
ISO |
1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine results in increased expression of ALOX5 mRNA |
CTD |
PMID:16386258 |
|
NCBI chr 4:149,531,329...149,578,696
Ensembl chr 4:149,531,515...149,578,743
|
|
G |
Ccr2 |
C-C motif chemokine receptor 2 |
increases expression |
ISO |
1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine results in increased expression of CCR2 mRNA |
CTD |
PMID:16386258 |
|
NCBI chr 8:123,734,465...123,742,483
Ensembl chr 8:123,734,430...123,742,100
|
|
G |
Cd68 |
Cd68 molecule |
increases expression |
ISO |
1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine results in increased expression of CD68 mRNA |
CTD |
PMID:16386258 |
|
NCBI chr10:54,381,814...54,383,693
Ensembl chr10:54,381,815...54,383,697
|
|
G |
Crp |
C-reactive protein |
increases expression |
ISO |
1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine results in increased expression of CRP mRNA |
CTD |
PMID:16386258 |
|
NCBI chr13:85,135,384...85,175,178
Ensembl chr13:85,124,977...85,175,178
|
|
G |
Gja1 |
gap junction protein, alpha 1 |
multiple interactions increases phosphorylation |
EXP |
AG 1879 inhibits the reaction [1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine results in increased phosphorylation of GJA1 protein]; resveratrol inhibits the reaction [1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine results in increased phosphorylation of GJA1 protein] |
CTD |
PMID:24079413 |
|
NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582
|
|
G |
Il1a |
interleukin 1 alpha |
increases expression |
ISO |
1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine results in increased expression of IL1A mRNA |
CTD |
PMID:16386258 |
|
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Il1b |
interleukin 1 beta |
increases expression |
ISO |
1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine results in increased expression of IL1B mRNA |
CTD |
PMID:16386258 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Kcnab2 |
potassium voltage-gated channel subfamily A regulatory beta subunit 2 |
multiple interactions |
EXP |
[KCNAB2 protein co-treated with NADP] results in increased reduction of 1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine |
CTD |
PMID:21296056 |
|
NCBI chr 5:162,899,511...162,988,057
Ensembl chr 5:162,901,896...162,988,243
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
increases phosphorylation multiple interactions |
EXP |
1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine results in increased phosphorylation of MAPK1 protein resveratrol inhibits the reaction [1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:24079413 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions increases phosphorylation |
EXP |
resveratrol inhibits the reaction [1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:24079413 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Olr1 |
oxidized low density lipoprotein receptor 1 |
increases expression |
ISO |
1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine results in increased expression of OLR1 mRNA |
CTD |
PMID:16386258 |
|
NCBI chr 4:162,926,436...162,949,057
Ensembl chr 4:162,926,439...162,948,523
|
|
G |
Ptafr |
platelet-activating factor receptor |
affects binding multiple interactions |
ISO |
1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine binds to PTAFR protein 1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine inhibits the reaction [Platelet Activating Factor binds to PTAFR protein] |
CTD |
PMID:16386258 |
|
NCBI chr 5:144,765,770...144,795,057
Ensembl chr 5:144,765,976...144,795,251
|
|
G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
increases expression |
ISO |
1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine results in increased expression of PTGS1 mRNA |
CTD |
PMID:16386258 |
|
NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
increases expression |
ISO |
1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine results in increased expression of PTGS2 mRNA |
CTD |
PMID:16386258 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Sele |
selectin E |
increases expression increases secretion |
ISO |
1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine results in increased expression of SELE mRNA 1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine results in increased secretion of SELE protein |
CTD |
PMID:16386258 |
|
NCBI chr13:76,402,841...76,412,741
Ensembl chr13:76,403,304...76,412,741
|
|
G |
Src |
SRC proto-oncogene, non-receptor tyrosine kinase |
multiple interactions increases phosphorylation |
EXP |
resveratrol inhibits the reaction [1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine results in increased phosphorylation of SRC protein] |
CTD |
PMID:24079413 |
|
NCBI chr 3:146,091,969...146,139,492
Ensembl chr 3:146,091,841...146,139,476
|
|
G |
Timp4 |
TIMP metallopeptidase inhibitor 4 |
increases expression |
ISO |
1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine results in increased expression of TIMP4 mRNA |
CTD |
PMID:16386258 |
|
NCBI chr 4:148,306,021...148,312,558
Ensembl chr 4:148,304,490...148,312,558
|
|
G |
Tnf |
tumor necrosis factor |
increases expression increases secretion |
ISO |
1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine results in increased expression of TNF mRNA 1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine results in increased secretion of TNF protein |
CTD |
PMID:16386258 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
increases expression multiple interactions |
ISO |
lysophosphatidic acid results in increased expression of ACTA2 mRNA N-(4-chlorophenyl)-1-((3-(furan-2-yl)phenyl)carbonyl)piperidine-3-carboxamide inhibits the reaction [lysophosphatidic acid results in increased expression of ACTA2 mRNA] |
CTD |
PMID:24706986 |
|
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions increases phosphorylation |
ISO EXP |
2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine inhibits the reaction [lysophosphatidic acid results in increased phosphorylation of AKT1 protein]; Resveratrol inhibits the reaction [lysophosphatidic acid results in increased phosphorylation of AKT1 protein] 1-Butanol inhibits the reaction [lysophosphatidic acid results in increased phosphorylation of AKT1 protein]; exoenzyme C3, Clostridium botulinum inhibits the reaction [lysophosphatidic acid results in increased phosphorylation of AKT1 protein] |
CTD |
PMID:14769825 PMID:17550345 PMID:20103642 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Alox5 |
arachidonate 5-lipoxygenase |
multiple interactions |
ISO |
ALOX5 protein promotes the reaction [lysophosphatidic acid results in increased abundance of Hydrogen Peroxide]; Masoprocol inhibits the reaction [ALOX5 protein promotes the reaction [lysophosphatidic acid results in increased abundance of Hydrogen Peroxide]]; zileuton inhibits the reaction [ALOX5 protein promotes the reaction [lysophosphatidic acid results in increased abundance of Hydrogen Peroxide]] |
CTD |
PMID:10698703 |
|
NCBI chr 4:149,531,329...149,578,696
Ensembl chr 4:149,531,515...149,578,743
|
|
G |
Alpl |
alkaline phosphatase, biomineralization associated |
multiple interactions |
ISO |
[Lithocholic Acid co-treated with lysophosphatidic acid] results in increased activity of ALPL protein |
CTD |
PMID:19646460 |
|
NCBI chr 5:149,951,397...150,006,424
Ensembl chr 5:149,951,409...150,006,446
|
|
G |
Bcar1 |
BCAR1 scaffold protein, Cas family member |
increases phosphorylation |
ISO |
lysophosphatidic acid results in increased phosphorylation of BCAR1 protein |
CTD |
PMID:11792571 |
|
NCBI chr19:39,679,215...39,713,907
Ensembl chr19:39,679,204...39,713,907
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
increases expression |
ISO |
lysophosphatidic acid analog results in increased expression of BCL2 protein; lysophosphatidic acid results in increased expression of BCL2 protein |
CTD |
PMID:23251428 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
C5 |
complement C5 |
increases expression |
ISO |
lysophosphatidic acid results in increased expression of HC protein |
CTD |
PMID:25822713 |
|
NCBI chr 3:18,270,696...18,361,994
Ensembl chr 3:18,270,696...18,361,994
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
ISO |
lysophosphatidic acid analog inhibits the reaction [cobaltous chloride results in increased activity of CASP3 protein]; lysophosphatidic acid inhibits the reaction [cobaltous chloride results in increased activity of CASP3 protein] |
CTD |
PMID:23251428 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Ccl12 |
C-C motif chemokine ligand 12 |
increases expression multiple interactions |
ISO |
lysophosphatidic acid results in increased expression of CCL12 protein 3-(4-(4-((1-(2-chlorophenyl)ethoxy)carbonyl amino)-3-methyl-5-isoxazolyl) benzylsulfanyl) propanoic acid inhibits the reaction [lysophosphatidic acid results in increased expression of CCL12 protein] |
CTD |
PMID:25822713 |
|
NCBI chr10:67,070,230...67,071,780
Ensembl chr10:67,070,230...67,071,780
|
|
G |
Ccl28 |
C-C motif chemokine ligand 28 |
multiple interactions increases expression |
ISO |
3-(4-(4-((1-(2-chlorophenyl)ethoxy)carbonyl amino)-3-methyl-5-isoxazolyl) benzylsulfanyl) propanoic acid inhibits the reaction [lysophosphatidic acid results in increased expression of CCL28 protein] |
CTD |
PMID:25822713 |
|
NCBI chr 2:51,601,354...51,625,999
Ensembl chr 2:51,601,331...51,625,997
|
|
G |
Ccn1 |
cellular communication network factor 1 |
multiple interactions increases expression |
ISO |
3-(4-(4-((1-(2-chlorophenyl)ethoxy)carbonyl amino)-3-methyl-5-isoxazolyl) benzylsulfanyl) propanoic acid inhibits the reaction [lysophosphatidic acid results in increased expression of CCN1 protein] |
CTD |
PMID:25822713 |
|
NCBI chr 2:234,562,410...234,565,370
Ensembl chr 2:234,562,408...234,565,484
|
|
G |
Ccn2 |
cellular communication network factor 2 |
increases expression multiple interactions |
EXP ISO |
lysophosphatidic acid results in increased expression of CCN2 protein N-(4-chlorophenyl)-1-((3-(furan-2-yl)phenyl)carbonyl)piperidine-3-carboxamide inhibits the reaction [lysophosphatidic acid results in increased expression of CCN2 mRNA] Simvastatin inhibits the reaction [lysophosphatidic acid results in increased expression of CCN2 protein]; Y 27632 inhibits the reaction [lysophosphatidic acid results in increased expression of CCN2 protein] |
CTD |
PMID:15200425 PMID:24706986 |
|
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
|
|
G |
Col1a2 |
collagen type I alpha 2 chain |
increases expression multiple interactions |
ISO |
lysophosphatidic acid results in increased expression of COL1A2 mRNA N-(4-chlorophenyl)-1-((3-(furan-2-yl)phenyl)carbonyl)piperidine-3-carboxamide inhibits the reaction [lysophosphatidic acid results in increased expression of COL1A2 mRNA] |
CTD |
PMID:24706986 |
|
NCBI chr 4:32,563,938...32,598,868
Ensembl chr 4:32,563,381...32,598,867
|
|
G |
Csf1 |
colony stimulating factor 1 |
increases expression |
ISO |
lysophosphatidic acid results in increased expression of CSF1 protein |
CTD |
PMID:25822713 |
|
NCBI chr 2:195,377,215...195,396,608
Ensembl chr 2:195,377,215...195,411,704
|
|
G |
Cxcl12 |
C-X-C motif chemokine ligand 12 |
increases expression multiple interactions |
ISO |
lysophosphatidic acid results in increased expression of CXCL12 protein 3-(4-(4-((1-(2-chlorophenyl)ethoxy)carbonyl amino)-3-methyl-5-isoxazolyl) benzylsulfanyl) propanoic acid inhibits the reaction [lysophosphatidic acid results in increased expression of CXCL12 protein] |
CTD |
PMID:25822713 |
|
NCBI chr 4:150,388,326...150,401,173
Ensembl chr 4:150,388,325...150,401,168
|
|
G |
Cxcl16 |
C-X-C motif chemokine ligand 16 |
increases expression multiple interactions |
ISO |
lysophosphatidic acid results in increased expression of CXCL16 protein 3-(4-(4-((1-(2-chlorophenyl)ethoxy)carbonyl amino)-3-methyl-5-isoxazolyl) benzylsulfanyl) propanoic acid inhibits the reaction [lysophosphatidic acid results in increased expression of CXCL16 protein] |
CTD |
PMID:25822713 |
|
NCBI chr10:55,166,721...55,171,316
Ensembl chr10:55,166,723...55,171,592
|
|
G |
Cxcr1 |
C-X-C motif chemokine receptor 1 |
multiple interactions decreases expression |
ISO |
lysophosphatidic acid inhibits the reaction [CXCR1 protein binds to LPAR1 protein]; lysophosphatidic acid results in decreased expression of [CXCR1 protein binds to LPAR1 protein] lysophosphatidic acid results in decreased expression of CXCR1 mRNA |
CTD |
PMID:16224106 |
|
NCBI chr 9:75,766,894...75,771,079
Ensembl chr 9:75,766,770...75,771,084
|
|
G |
Dgka |
diacylglycerol kinase, alpha |
multiple interactions |
ISO |
DGKA protein promotes the reaction [lysophosphatidic acid results in increased activity of PIP5K1A protein] |
CTD |
PMID:10913605 |
|
NCBI chr 7:1,148,734...1,175,324
Ensembl chr 7:1,148,735...1,175,110
|
|
G |
Egfr |
epidermal growth factor receptor |
multiple interactions increases phosphorylation |
ISO |
GNA13 mutant form inhibits the reaction [lysophosphatidic acid results in increased phosphorylation of EGFR protein]; Pertussis Toxin inhibits the reaction [lysophosphatidic acid results in increased phosphorylation of EGFR protein]; resveratrol inhibits the reaction [lysophosphatidic acid results in increased phosphorylation of EGFR protein] |
CTD |
PMID:23127547 |
|
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
multiple interactions increases phosphorylation |
EXP |
1-Butanol inhibits the reaction [lysophosphatidic acid results in increased phosphorylation of EIF4EBP1 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [lysophosphatidic acid results in increased phosphorylation of EIF4EBP1 protein]; 2-butanol inhibits the reaction [lysophosphatidic acid results in increased phosphorylation of EIF4EBP1 protein]; exoenzyme C3, Clostridium botulinum inhibits the reaction [lysophosphatidic acid results in increased phosphorylation of EIF4EBP1 protein] |
CTD |
PMID:14769825 |
|
NCBI chr16:64,792,595...64,805,984
Ensembl chr16:64,790,226...64,805,984
|
|
G |
Enpp2 |
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
multiple interactions decreases expression |
ISO EXP |
1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [[ENPP2 protein co-treated with Capsaicin] results in increased abundance of lysophosphatidic acid]; 3-(2-methoxybenzylamino)-2-phenylpiperidine inhibits the reaction [[ENPP2 protein co-treated with Capsaicin] results in increased abundance of lysophosphatidic acid]; [[Capsaicin results in increased chemical synthesis of Lysophosphatidylcholines] which results in increased secretion of Lysophosphatidylcholines] promotes the reaction [ENPP2 results in increased chemical synthesis of lysophosphatidic acid]; [[ONO-8430506 results in decreased activity of ENPP2 protein] which results in decreased abundance of lysophosphatidic acid] which results in decreased expression of NFE2L2; [[ONO-8430506 results in decreased activity of ENPP2 protein] which results in decreased chemical synthesis of and results in decreased abundance of lysophosphatidic acid] which results in increased expression of ENPP2 mRNA; [ENPP2 protein co-treated with Capsaicin] results in increased abundance of lysophosphatidic acid; [ENPP2 protein co-treated with Lysophosphatidylcholines] results in increased chemical synthesis of lysophosphatidic acid; [ONO-8430506 results in decreased activity of ENPP2 protein] which results in decreased abundance of lysophosphatidic acid; [ONO-8430506 results in decreased activity of ENPP2 protein] which results in decreased chemical synthesis of and results in decreased abundance of lysophosphatidic acid; arachidonyltrifluoromethane inhibits the reaction [[ENPP2 protein co-treated with Capsaicin] results in increased abundance of lysophosphatidic acid]; bisindolylmaleimide I inhibits the reaction [[ENPP2 protein co-treated with Capsaicin] results in increased abundance of lysophosphatidic acid]; Dizocilpine Maleate inhibits the reaction [[ENPP2 protein co-treated with Capsaicin] results in increased abundance of lysophosphatidic acid]; IL1B protein inhibits the reaction [lysophosphatidic acid results in decreased expression of ENPP2 protein]; TNF protein inhibits the reaction [lysophosphatidic acid results in decreased expression of ENPP2 protein]; U 0126 inhibits the reaction [[ENPP2 protein co-treated with Capsaicin] results in increased abundance of lysophosphatidic acid]; xestospongin C inhibits the reaction [[ENPP2 protein co-treated with Capsaicin] results in increased abundance of lysophosphatidic acid] lysophosphatidic acid inhibits the reaction [ENPP2 mutant form results in decreased expression of MBP mRNA] |
CTD |
PMID:18594965 PMID:19014389 PMID:24599971 PMID:24747415 PMID:25398768 PMID:25896349 More...
|
|
NCBI chr 7:86,202,345...86,325,050
Ensembl chr 7:86,202,350...86,324,827
|
|
G |
Epo |
erythropoietin |
multiple interactions |
ISO |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[lysophosphatidic acid co-treated with KITLG protein co-treated with EPO protein] results in increased expression of TFRC protein]; [lysophosphatidic acid co-treated with KITLG protein co-treated with EPO protein] results in increased expression of GATA1 mRNA; [lysophosphatidic acid co-treated with KITLG protein co-treated with EPO protein] results in increased expression of TFRC mRNA; [lysophosphatidic acid co-treated with KITLG protein co-treated with EPO protein] results in increased expression of TFRC protein; lysophosphatidic acid promotes the reaction [[KITLG protein co-treated with EPO protein] results in increased expression of GATA1 mRNA]; lysophosphatidic acid promotes the reaction [[KITLG protein co-treated with EPO protein] results in increased expression of GYPA mRNA]; lysophosphatidic acid promotes the reaction [[KITLG protein co-treated with EPO protein] results in increased expression of TFRC mRNA]; lysophosphatidic acid promotes the reaction [[KITLG protein co-treated with EPO protein] results in increased expression of TFRC protein]; Quercetin inhibits the reaction [[lysophosphatidic acid co-treated with KITLG protein co-treated with EPO protein] results in increased expression of GATA1 mRNA]; Quercetin inhibits the reaction [[lysophosphatidic acid co-treated with KITLG protein co-treated with EPO protein] results in increased expression of TFRC mRNA]; Quercetin inhibits the reaction [[lysophosphatidic acid co-treated with KITLG protein co-treated with EPO protein] results in increased expression of TFRC protein]; WP1066 inhibits the reaction [[lysophosphatidic acid co-treated with KITLG protein co-treated with EPO protein] results in increased expression of TFRC protein] |
CTD |
PMID:21915944 |
|
NCBI chr12:19,204,258...19,207,948
Ensembl chr12:19,204,508...19,207,946
|
|
G |
Gata1 |
GATA binding protein 1 |
multiple interactions |
ISO |
[lysophosphatidic acid co-treated with KITLG protein co-treated with EPO protein] results in increased expression of GATA1 mRNA; lysophosphatidic acid promotes the reaction [[KITLG protein co-treated with EPO protein] results in increased expression of GATA1 mRNA]; Quercetin inhibits the reaction [[lysophosphatidic acid co-treated with KITLG protein co-treated with EPO protein] results in increased expression of GATA1 mRNA] |
CTD |
PMID:21915944 |
|
NCBI chr X:14,529,706...14,537,530
Ensembl chr X:14,529,702...14,537,530
|
|
G |
Gna13 |
G protein subunit alpha 13 |
multiple interactions |
ISO |
GNA13 mutant form inhibits the reaction [lysophosphatidic acid results in increased phosphorylation of EGFR protein] |
CTD |
PMID:23127547 |
|
NCBI chr10:94,337,939...94,370,774
Ensembl chr10:94,337,725...94,370,774
|
|
G |
Gypa |
glycophorin A |
multiple interactions |
ISO |
lysophosphatidic acid promotes the reaction [[KITLG protein co-treated with EPO protein] results in increased expression of GYPA mRNA] |
CTD |
PMID:21915944 |
|
NCBI chr19:27,450,304...27,465,940
Ensembl chr19:27,450,308...27,465,822
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
multiple interactions increases expression |
ISO |
L-4F peptide inhibits the reaction [lysophosphatidic acid results in increased expression of HIF1A protein]; resveratrol inhibits the reaction [lysophosphatidic acid results in increased expression of HIF1A protein] [lysophosphatidic acid results in increased expression of HIF1A protein] which results in increased expression of VEGFA mRNA; [lysophosphatidic acid results in increased expression of HIF1A protein] which results in increased expression of VEGFA protein; lysophosphatidic acid results in increased expression of HIF1A protein |
CTD |
PMID:17919812 PMID:22537771 |
|
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Hspb1 |
heat shock protein family B (small) member 1 |
multiple interactions increases phosphorylation |
EXP |
MK2i peptide inhibits the reaction [lysophosphatidic acid results in increased phosphorylation of HSPB1 protein]; SB 203580 inhibits the reaction [lysophosphatidic acid results in increased phosphorylation of HSPB1 protein] |
CTD |
PMID:20864298 |
|
NCBI chr12:20,794,014...20,795,675
Ensembl chr12:20,794,028...20,795,743
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO |
IL1B protein inhibits the reaction [lysophosphatidic acid results in decreased expression of ENPP2 protein] |
CTD |
PMID:25896349 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il6 |
interleukin 6 |
increases secretion |
ISO |
lysophosphatidic acid results in increased secretion of IL6 protein |
CTD |
PMID:21821728 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Il6st |
interleukin 6 cytokine family signal transducer |
multiple interactions increases expression |
ISO |
3-(4-(4-((1-(2-chlorophenyl)ethoxy)carbonyl amino)-3-methyl-5-isoxazolyl) benzylsulfanyl) propanoic acid inhibits the reaction [lysophosphatidic acid results in increased expression of IL6ST protein] |
CTD |
PMID:25822713 |
|
NCBI chr 2:44,065,979...44,106,255
Ensembl chr 2:44,066,130...44,109,936
|
|
G |
Kitlg |
KIT ligand |
multiple interactions |
ISO |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[lysophosphatidic acid co-treated with KITLG protein co-treated with EPO protein] results in increased expression of TFRC protein]; [lysophosphatidic acid co-treated with KITLG protein co-treated with EPO protein] results in increased expression of GATA1 mRNA; [lysophosphatidic acid co-treated with KITLG protein co-treated with EPO protein] results in increased expression of TFRC mRNA; [lysophosphatidic acid co-treated with KITLG protein co-treated with EPO protein] results in increased expression of TFRC protein; lysophosphatidic acid promotes the reaction [[KITLG protein co-treated with EPO protein] results in increased expression of GATA1 mRNA]; lysophosphatidic acid promotes the reaction [[KITLG protein co-treated with EPO protein] results in increased expression of GYPA mRNA]; lysophosphatidic acid promotes the reaction [[KITLG protein co-treated with EPO protein] results in increased expression of TFRC mRNA]; lysophosphatidic acid promotes the reaction [[KITLG protein co-treated with EPO protein] results in increased expression of TFRC protein]; Quercetin inhibits the reaction [[lysophosphatidic acid co-treated with KITLG protein co-treated with EPO protein] results in increased expression of GATA1 mRNA]; Quercetin inhibits the reaction [[lysophosphatidic acid co-treated with KITLG protein co-treated with EPO protein] results in increased expression of TFRC mRNA]; Quercetin inhibits the reaction [[lysophosphatidic acid co-treated with KITLG protein co-treated with EPO protein] results in increased expression of TFRC protein]; WP1066 inhibits the reaction [[lysophosphatidic acid co-treated with KITLG protein co-treated with EPO protein] results in increased expression of TFRC protein] |
CTD |
PMID:21915944 |
|
NCBI chr 7:34,896,075...34,977,215
Ensembl chr 7:34,896,053...34,977,214
|
|
G |
Kng1 |
kininogen 1 |
multiple interactions |
EXP |
KNG1 protein inhibits the reaction [[Wortmannin co-treated with lysophosphatidic acid] results in increased phosphorylation of PTK2 protein] |
CTD |
PMID:10537051 |
|
NCBI chr11:77,812,757...77,835,555
Ensembl chr11:77,812,752...77,835,555
|
|
G |
Lama3 |
laminin subunit alpha 3 |
increases expression |
ISO |
lysophosphatidic acid results in increased expression of LAMA3 mRNA |
CTD |
PMID:15541073 |
|
NCBI chr18:3,523,168...3,751,722
Ensembl chr18:3,523,133...3,751,353
|
|
G |
Lamb3 |
laminin subunit beta 3 |
increases expression |
ISO |
lysophosphatidic acid results in increased expression of LAMB3 mRNA |
CTD |
PMID:15541073 |
|
NCBI chr13:104,833,810...104,875,405
Ensembl chr13:104,833,873...104,875,405
|
|
G |
Lamc2 |
laminin subunit gamma 2 |
increases expression |
ISO |
lysophosphatidic acid results in increased expression of LAMC2 mRNA |
CTD |
PMID:15541073 |
|
NCBI chr13:65,284,664...65,344,164
Ensembl chr13:65,284,664...65,344,200
|
|
G |
Lpar1 |
lysophosphatidic acid receptor 1 |
increases response to substance multiple interactions |
ISO |
LPAR1 protein results in increased susceptibility to lysophosphatidic acid LPAR1 protein affects the reaction [lysophosphatidic acid results in increased stability of and affects the localization of NFE2L2 protein]; lysophosphatidic acid inhibits the reaction [CXCR1 protein binds to LPAR1 protein]; lysophosphatidic acid results in decreased expression of [CXCR1 protein binds to LPAR1 protein] |
CTD |
PMID:16224106 PMID:16809448 PMID:25398768 |
|
NCBI chr 5:73,229,047...73,347,874
Ensembl chr 5:73,229,625...73,369,895
|
|
G |
Lpar3 |
lysophosphatidic acid receptor 3 |
multiple interactions |
ISO |
Endocannabinoids inhibits the reaction [lysophosphatidic acid binds to and results in increased activity of LPAR3 protein]; lysophosphatidic acid binds to and results in increased activity of LPAR3 protein |
CTD |
PMID:30102254 |
|
NCBI chr 2:235,125,234...235,193,916
Ensembl chr 2:235,149,065...235,193,357
|
|
G |
Lpar5 |
lysophosphatidic acid receptor 5 |
multiple interactions |
ISO |
Endocannabinoids inhibits the reaction [lysophosphatidic acid binds to and results in increased activity of LPAR5 protein]; lysophosphatidic acid binds to and results in increased activity of LPAR5 protein |
CTD |
PMID:30102254 |
|
NCBI chr 4:157,870,493...157,883,979
Ensembl chr 4:157,881,796...157,882,950
|
|
G |
Lpar6 |
lysophosphatidic acid receptor 6 |
multiple interactions |
ISO |
lysophosphatidic acid binds to and results in increased activity of LPAR6 protein |
CTD |
PMID:18297070 |
|
NCBI chr15:48,416,548...48,418,357
Ensembl chr15:48,416,544...48,422,331
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions increases phosphorylation |
ISO EXP |
Hydrogen Peroxide promotes the reaction [lysophosphatidic acid results in increased phosphorylation of MAPK1 protein]; resveratrol inhibits the reaction [lysophosphatidic acid results in increased phosphorylation of MAPK1 protein] 1-Butanol inhibits the reaction [PLD1 protein affects the reaction [lysophosphatidic acid results in increased phosphorylation of MAPK1 protein]]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [lysophosphatidic acid results in increased phosphorylation of MAPK1 protein]; Pertussis Toxin inhibits the reaction [lysophosphatidic acid results in increased phosphorylation of MAPK1 protein]; PLD1 protein affects the reaction [lysophosphatidic acid results in increased phosphorylation of MAPK1 protein]; U 0126 inhibits the reaction [lysophosphatidic acid results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:11243883 PMID:12657697 PMID:15081308 PMID:17919812 PMID:21179406 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions increases phosphorylation |
ISO EXP |
Hydrogen Peroxide promotes the reaction [lysophosphatidic acid results in increased phosphorylation of MAPK3 protein]; resveratrol inhibits the reaction [lysophosphatidic acid results in increased phosphorylation of MAPK3 protein] 1-Butanol inhibits the reaction [PLD1 protein affects the reaction [lysophosphatidic acid results in increased phosphorylation of MAPK3 protein]]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [lysophosphatidic acid results in increased phosphorylation of MAPK3 protein]; Pertussis Toxin inhibits the reaction [lysophosphatidic acid results in increased phosphorylation of MAPK3 protein]; PLD1 protein affects the reaction [lysophosphatidic acid results in increased phosphorylation of MAPK3 protein]; U 0126 inhibits the reaction [lysophosphatidic acid results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:11243883 PMID:12657697 PMID:15081308 PMID:17919812 PMID:21179406 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mbp |
myelin basic protein |
multiple interactions |
EXP |
lysophosphatidic acid inhibits the reaction [ENPP2 mutant form results in decreased expression of MBP mRNA] |
CTD |
PMID:18594965 |
|
NCBI chr18:75,855,878...75,966,404
Ensembl chr18:75,855,878...75,966,404
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
multiple interactions increases expression |
ISO |
gefitinib inhibits the reaction [lysophosphatidic acid results in increased expression of MMP9 mRNA]; gefitinib promotes the reaction [resveratrol inhibits the reaction [lysophosphatidic acid results in increased expression of MMP9 mRNA]]; resveratrol inhibits the reaction [lysophosphatidic acid results in increased expression of MMP9 mRNA]; resveratrol promotes the reaction [gefitinib inhibits the reaction [lysophosphatidic acid results in increased expression of MMP9 mRNA]] |
CTD |
PMID:23127547 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
increases phosphorylation |
EXP |
lysophosphatidic acid results in increased phosphorylation of MTOR protein |
CTD |
PMID:14769825 |
|
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
|
|
G |
Myl9 |
myosin light chain 9 |
increases phosphorylation multiple interactions |
ISO |
lysophosphatidic acid results in increased phosphorylation of MYL9 protein Farnesol analog inhibits the reaction [lysophosphatidic acid results in increased phosphorylation of MYL9 protein]; geranylgeraniol analog inhibits the reaction [lysophosphatidic acid results in increased phosphorylation of MYL9 protein] |
CTD |
PMID:24587105 |
|
NCBI chr 3:145,281,943...145,288,333
Ensembl chr 3:145,281,937...145,288,333
|
|
G |
Mylk |
myosin light chain kinase |
affects response to substance |
ISO |
MYLK protein affects the susceptibility to lysophosphatidic acid |
CTD |
PMID:10640419 |
|
NCBI chr11:65,783,008...66,030,239
Ensembl chr11:65,783,008...66,030,261
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions |
ISO |
LPAR1 protein affects the reaction [lysophosphatidic acid results in increased stability of and affects the localization of NFE2L2 protein]; lysophosphatidic acid results in increased stability of and affects the localization of NFE2L2 protein [[ONO-8430506 results in decreased activity of ENPP2 protein] which results in decreased abundance of lysophosphatidic acid] which results in decreased expression of NFE2L2 |
CTD |
PMID:25398768 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nppa |
natriuretic peptide A |
multiple interactions increases expression |
EXP |
Pertussis Toxin inhibits the reaction [lysophosphatidic acid results in increased expression of NPPA protein]; Y 27632 inhibits the reaction [lysophosphatidic acid results in increased expression of NPPA protein] |
CTD |
PMID:15081308 PMID:25449040 |
|
NCBI chr 5:158,429,042...158,430,351
Ensembl chr 5:158,429,042...158,430,351
|
|
G |
Pak1 |
p21 (RAC1) activated kinase 1 |
increases activity multiple interactions |
EXP |
lysophosphatidic acid results in increased activity of PAK1 protein 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [lysophosphatidic acid results in increased activity of PAK1 protein]; diphenyleneiodonium inhibits the reaction [lysophosphatidic acid results in increased activity of PAK1 protein]; Genistein inhibits the reaction [lysophosphatidic acid results in increased activity of PAK1 protein]; Pertussis Toxin inhibits the reaction [lysophosphatidic acid results in increased activity of PAK1 protein] |
CTD |
PMID:11855845 |
|
NCBI chr 1:152,111,172...152,226,390
Ensembl chr 1:152,111,188...152,226,383
|
|
G |
Pip5k1a |
phosphatidylinositol-4-phosphate 5-kinase, type 1, alpha |
multiple interactions increases activity |
ISO |
1-Butanol inhibits the reaction [lysophosphatidic acid results in increased activity of PIP5K1A protein]; DGKA protein promotes the reaction [lysophosphatidic acid results in increased activity of PIP5K1A protein] |
CTD |
PMID:10913605 |
|
NCBI chr 2:182,628,299...182,671,584
Ensembl chr 2:182,628,300...182,671,598
|
|
G |
Plau |
plasminogen activator, urokinase |
multiple interactions increases expression |
ISO |
gefitinib inhibits the reaction [lysophosphatidic acid results in increased expression of PLAU mRNA]; gefitinib promotes the reaction [resveratrol inhibits the reaction [lysophosphatidic acid results in increased expression of PLAU mRNA]]; resveratrol inhibits the reaction [lysophosphatidic acid results in increased expression of PLAU mRNA]; resveratrol promotes the reaction [gefitinib inhibits the reaction [lysophosphatidic acid results in increased expression of PLAU mRNA]] |
CTD |
PMID:23127547 |
|
NCBI chr15:3,456,230...3,462,732
Ensembl chr15:3,456,232...3,462,775
|
|
G |
Pld1 |
phospholipase D1 |
multiple interactions increases activity |
EXP |
1-Butanol inhibits the reaction [PLD1 protein affects the reaction [lysophosphatidic acid results in increased phosphorylation of MAPK1 protein]]; 1-Butanol inhibits the reaction [PLD1 protein affects the reaction [lysophosphatidic acid results in increased phosphorylation of MAPK3 protein]]; bisindolylmaleimide I inhibits the reaction [lysophosphatidic acid results in increased activity of PLD1 protein]; Pertussis Toxin inhibits the reaction [lysophosphatidic acid results in increased activity of PLD1 protein]; PLD1 protein affects the reaction [lysophosphatidic acid results in increased phosphorylation of MAPK1 protein]; PLD1 protein affects the reaction [lysophosphatidic acid results in increased phosphorylation of MAPK3 protein]; toxB protein, Clostridium difficile inhibits the reaction [lysophosphatidic acid results in increased phosphorylation of PLD1 protein] |
CTD |
PMID:11243883 PMID:14769825 |
|
NCBI chr 2:110,849,205...111,047,304
Ensembl chr 2:110,893,608...111,047,692
|
|
G |
Ppp1r12a |
protein phosphatase 1, regulatory subunit 12A |
increases phosphorylation multiple interactions |
EXP |
lysophosphatidic acid results in increased phosphorylation of PPP1R12A protein Y 27632 inhibits the reaction [lysophosphatidic acid results in increased phosphorylation of PPP1R12A protein] |
CTD |
PMID:25449040 |
|
NCBI chr 7:43,482,808...43,593,689
Ensembl chr 7:43,482,803...43,593,425
|
|
G |
Ptk2 |
protein tyrosine kinase 2 |
increases phosphorylation multiple interactions |
ISO EXP |
lysophosphatidic acid results in increased phosphorylation of PTK2 protein [wortmannin co-treated with lysophosphatidic acid] results in increased phosphorylation of PTK2 protein; KNG1 protein inhibits the reaction [[wortmannin co-treated with lysophosphatidic acid] results in increased phosphorylation of PTK2 protein] [wortmannin co-treated with lysophosphatidic acid] results in increased phosphorylation of PTK2 protein; Atropine inhibits the reaction [oxotremorine M inhibits the reaction [[wortmannin co-treated with lysophosphatidic acid] results in increased phosphorylation of PTK2 protein]]; oxotremorine M inhibits the reaction [[wortmannin co-treated with lysophosphatidic acid] results in increased phosphorylation of PTK2 protein] |
CTD |
PMID:10537051 PMID:11792571 |
|
NCBI chr 7:105,126,725...105,331,848
Ensembl chr 7:105,126,728...105,331,783
|
|
G |
Ptk2b |
protein tyrosine kinase 2 beta |
increases phosphorylation |
ISO |
lysophosphatidic acid results in increased phosphorylation of PTK2B protein |
CTD |
PMID:11792571 |
|
NCBI chr15:40,360,722...40,481,235
Ensembl chr15:40,360,723...40,481,282
|
|
G |
Rhoa |
ras homolog family member A |
increases activity multiple interactions |
EXP ISO |
lysophosphatidic acid results in increased activity of RHOA protein Farnesol analog inhibits the reaction [lysophosphatidic acid results in increased activity of RHOA protein]; geranylgeraniol analog inhibits the reaction [lysophosphatidic acid results in increased activity of RHOA protein] |
CTD |
PMID:15081308 PMID:24587105 |
|
NCBI chr 8:108,991,926...109,025,746
Ensembl chr 8:108,991,954...109,025,746
|
|
G |
Rhoc |
ras homolog family member C |
multiple interactions increases activity |
ISO |
Farnesol analog inhibits the reaction [lysophosphatidic acid results in increased activity of RHOC protein]; geranylgeraniol analog inhibits the reaction [lysophosphatidic acid results in increased activity of RHOC protein] |
CTD |
PMID:24587105 |
|
NCBI chr 2:192,287,065...192,293,292
Ensembl chr 2:192,287,130...192,295,306
|
|
G |
Rps6kb1 |
ribosomal protein S6 kinase B1 |
increases phosphorylation multiple interactions |
ISO EXP |
lysophosphatidic acid results in increased phosphorylation of RPS6KB1 protein resveratrol inhibits the reaction [lysophosphatidic acid results in increased phosphorylation of RPS6KB1 protein] 1-Butanol inhibits the reaction [lysophosphatidic acid results in increased phosphorylation of RPS6KB1 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [lysophosphatidic acid results in increased phosphorylation of RPS6KB1 protein]; exoenzyme C3, Clostridium botulinum inhibits the reaction [lysophosphatidic acid results in increased phosphorylation of RPS6KB1 protein] |
CTD |
PMID:14769825 PMID:17919812 |
|
NCBI chr10:71,323,777...71,367,908
Ensembl chr10:71,323,777...71,367,908
|
|
G |
Tfrc |
transferrin receptor |
multiple interactions |
ISO |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[lysophosphatidic acid co-treated with KITLG protein co-treated with EPO protein] results in increased expression of TFRC protein]; [lysophosphatidic acid co-treated with KITLG protein co-treated with EPO protein] results in increased expression of TFRC mRNA; [lysophosphatidic acid co-treated with KITLG protein co-treated with EPO protein] results in increased expression of TFRC protein; lysophosphatidic acid promotes the reaction [[KITLG protein co-treated with EPO protein] results in increased expression of TFRC mRNA]; lysophosphatidic acid promotes the reaction [[KITLG protein co-treated with EPO protein] results in increased expression of TFRC protein]; Quercetin inhibits the reaction [[lysophosphatidic acid co-treated with KITLG protein co-treated with EPO protein] results in increased expression of TFRC mRNA]; Quercetin inhibits the reaction [[lysophosphatidic acid co-treated with KITLG protein co-treated with EPO protein] results in increased expression of TFRC protein]; WP1066 inhibits the reaction [[lysophosphatidic acid co-treated with KITLG protein co-treated with EPO protein] results in increased expression of TFRC protein] |
CTD |
PMID:21915944 |
|
NCBI chr11:68,163,413...68,185,257
Ensembl chr11:68,163,413...68,185,257
|
|
G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
multiple interactions increases expression |
ISO |
3-(4-(4-((1-(2-chlorophenyl)ethoxy)carbonyl amino)-3-methyl-5-isoxazolyl) benzylsulfanyl) propanoic acid inhibits the reaction [lysophosphatidic acid results in increased expression of TIMP1 protein] |
CTD |
PMID:25822713 |
|
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
TNF protein inhibits the reaction [lysophosphatidic acid results in decreased expression of ENPP2 protein] |
CTD |
PMID:25896349 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Vegfa |
vascular endothelial growth factor A |
increases expression multiple interactions |
ISO |
[lysophosphatidic acid results in increased expression of HIF1A protein] which results in increased expression of VEGFA mRNA; [lysophosphatidic acid results in increased expression of HIF1A protein] which results in increased expression of VEGFA protein resveratrol inhibits the reaction [lysophosphatidic acid results in increased expression of VEGFA protein] |
CTD |
PMID:17919812 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
|
G |
Lipc |
lipase C, hepatic type |
multiple interactions decreases abundance |
ISO |
[LIPC gene mutant form co-treated with LIPG gene mutant form] results in decreased abundance of 1-stearoyl-2-oleoyl-sn-glycerol LIPC gene mutant form results in decreased abundance of 1-stearoyl-2-oleoyl-sn-glycerol |
CTD |
PMID:24777581 |
|
NCBI chr 8:71,509,633...71,635,663
Ensembl chr 8:71,509,635...71,635,464
|
|
G |
Lipg |
lipase G, endothelial type |
decreases abundance multiple interactions |
ISO |
LIPG gene mutant form results in decreased abundance of 1-stearoyl-2-oleoyl-sn-glycerol [LIPC gene mutant form co-treated with LIPG gene mutant form] results in decreased abundance of 1-stearoyl-2-oleoyl-sn-glycerol |
CTD |
PMID:24777581 |
|
NCBI chr18:68,514,923...68,536,105
Ensembl chr18:68,514,923...68,536,260
|
|
|
G |
Abca1 |
ATP binding cassette subfamily A member 1 |
multiple interactions |
ISO |
1-oleoyl-2-acetylglycerol inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of Cholesterol]]; 1-oleoyl-2-acetylglycerol results in increased phosphorylation of and results in decreased expression of ABCA1 protein |
CTD |
PMID:16118212 |
|
NCBI chr 5:67,678,267...67,801,162
Ensembl chr 5:67,681,297...67,801,170
|
|
G |
Apoa1 |
apolipoprotein A1 |
multiple interactions |
ISO |
1-oleoyl-2-acetylglycerol inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of Cholesterol]] |
CTD |
PMID:16118212 |
|
NCBI chr 8:46,527,251...46,529,035
Ensembl chr 8:46,527,144...46,529,035
|
|
G |
Chrm1 |
cholinergic receptor, muscarinic 1 |
multiple interactions |
ISO |
1-oleoyl-2-acetylglycerol promotes the reaction [[Carbachol results in increased activity of CHRM1 protein] which results in increased abundance of Calcium] |
CTD |
PMID:18316702 |
|
NCBI chr 1:205,567,226...205,583,001
Ensembl chr 1:205,567,220...205,582,356
|
|
G |
Fgg |
fibrinogen gamma chain |
increases expression |
ISO |
1-oleoyl-2-acetylglycerol results in increased expression of FGG mRNA |
CTD |
PMID:2440878 |
|
NCBI chr 2:168,354,880...168,362,325
Ensembl chr 2:168,355,013...168,362,322
|
|
G |
Ins2 |
insulin 2 |
affects response to substance |
ISO |
INS protein affects the susceptibility to 1-oleoyl-2-acetylglycerol |
CTD |
PMID:22031853 |
|
NCBI chr 1:197,843,277...197,992,522
Ensembl chr 1:197,843,281...197,864,775
|
|
G |
Pthlh |
parathyroid hormone-like hormone |
increases secretion |
EXP |
1-oleoyl-2-acetylglycerol results in increased secretion of PTHLH protein |
CTD |
PMID:7946399 |
|
NCBI chr 4:180,188,792...180,199,847
Ensembl chr 4:180,188,792...180,199,847
|
|
G |
Trpa1 |
transient receptor potential cation channel, subfamily A, member 1 |
increases activity multiple interactions |
ISO |
1-oleoyl-2-acetylglycerol results in increased activity of TRPA1 protein Ruthenium Red inhibits the reaction [1-oleoyl-2-acetylglycerol results in increased activity of TRPA1 protein] |
CTD |
PMID:15046718 |
|
NCBI chr 5:4,379,862...4,434,133
Ensembl chr 5:4,379,999...4,433,570
|
|
G |
Trpc3 |
transient receptor potential cation channel, subfamily C, member 3 |
increases activity multiple interactions |
ISO |
1-oleoyl-2-acetylglycerol results in increased activity of TRPC3 protein ethyl-1-(4-(2*3*3-trichloroacrylamide)phenyl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylate inhibits the reaction [1-oleoyl-2-acetylglycerol results in increased activity of TRPC3 protein] 1-oleoyl-2-acetylglycerol affects the reaction [TRPC3 protein affects the transport of Calcium]; 1-oleoyl-2-acetylglycerol promotes the reaction [TRPC3 protein results in increased transport of Barium]; 1-oleoyl-2-acetylglycerol promotes the reaction [TRPC3 protein results in increased transport of Calcium] |
CTD |
PMID:11042129 PMID:12700192 PMID:16522635 PMID:17351372 PMID:18316702 PMID:19289841 More...
|
|
NCBI chr 2:119,481,313...119,619,333
Ensembl chr 2:119,481,400...119,558,855
|
|
G |
Trpc4 |
transient receptor potential cation channel, subfamily C, member 4 |
multiple interactions |
ISO |
TRPC4 protein affects the reaction [1-oleoyl-2-acetylglycerol results in increased transport of Strontium] |
CTD |
PMID:11830588 |
|
NCBI chr 2:138,307,676...138,476,856
Ensembl chr 2:138,308,084...138,476,768
|
|
G |
Trpc5 |
transient receptor potential cation channel, subfamily C, member 5 |
multiple interactions |
ISO |
1-oleoyl-2-acetylglycerol affects the reaction [TRPC5 protein affects the transport of Calcium] |
CTD |
PMID:17351372 |
|
NCBI chr X:107,946,163...108,230,991
Ensembl chr X:107,939,131...108,230,991
|
|
G |
Trpc6 |
transient receptor potential cation channel, subfamily C, member 6 |
increases activity multiple interactions affects response to substance |
ISO EXP |
1-oleoyl-2-acetylglycerol results in increased activity of TRPC6 protein 4-((3,4-(methylenedioxy)benzyl)amino)-6-methoxyquinazoline analog inhibits the reaction [1-oleoyl-2-acetylglycerol results in increased activity of TRPC6 protein]; 8-bromocyclic GMP inhibits the reaction [1-oleoyl-2-acetylglycerol results in increased activity of TRPC6 protein]; KT 5823 inhibits the reaction [4-((3,4-(methylenedioxy)benzyl)amino)-6-methoxyquinazoline analog inhibits the reaction [1-oleoyl-2-acetylglycerol results in increased activity of TRPC6 protein]]; S-Nitroso-N-Acetylpenicillamine inhibits the reaction [1-oleoyl-2-acetylglycerol results in increased activity of TRPC6 protein] 1-oleoyl-2-acetylglycerol results in increased activity of TRPC6 protein; 1-oleoyl-2-acetylglycerol results in increased activity of TRPC6 protein mutant form TRPC6 protein affects the susceptibility to 1-oleoyl-2-acetylglycerol |
CTD |
PMID:18316702 PMID:20177073 PMID:22031853 |
|
NCBI chr 8:5,759,387...5,864,000
Ensembl chr 8:5,758,935...5,828,092
|
|
G |
Trpm6 |
transient receptor potential cation channel, subfamily M, member 6 |
multiple interactions |
ISO |
Gadolinium inhibits the reaction [TRPM6 protein affects the reaction [1-oleoyl-2-acetylglycerol results in increased transport of Calcium]]; Lanthanum inhibits the reaction [TRPM6 protein affects the reaction [1-oleoyl-2-acetylglycerol results in increased transport of Calcium]]; TRPM6 protein affects the reaction [1-oleoyl-2-acetylglycerol results in increased transport of Barium]; TRPM6 protein affects the reaction [1-oleoyl-2-acetylglycerol results in increased transport of Calcium]; TRPM6 protein affects the reaction [1-oleoyl-2-acetylglycerol results in increased transport of Strontium] |
CTD |
PMID:11988098 |
|
NCBI chr 1:216,136,407...216,320,523
Ensembl chr 1:216,170,038...216,320,520
|
|
|
G |
Lipg |
lipase G, endothelial type |
increases hydrolysis |
ISO |
LIPG protein results in increased hydrolysis of 1-O-hexadecyl-2-arachidonyl-sn-glycero-3-phosphocholine |
CTD |
PMID:15953354 |
|
NCBI chr18:68,514,923...68,536,105
Ensembl chr18:68,514,923...68,536,260
|
|
|
G |
Lipc |
lipase C, hepatic type |
decreases abundance |
ISO |
LIPC gene mutant form results in decreased abundance of 1-palmitoyl-2-oleoyl-sn-glycerol |
CTD |
PMID:24777581 |
|
NCBI chr 8:71,509,633...71,635,663
Ensembl chr 8:71,509,635...71,635,464
|
|
G |
Lipg |
lipase G, endothelial type |
decreases abundance |
ISO |
LIPG gene mutant form results in decreased abundance of 1-palmitoyl-2-oleoyl-sn-glycerol |
CTD |
PMID:24777581 |
|
NCBI chr18:68,514,923...68,536,105
Ensembl chr18:68,514,923...68,536,260
|
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
multiple interactions |
ISO |
1-stearoyl-2-arachidonoylglycerol inhibits the reaction [TGFB1 protein results in increased expression of COL1A1 mRNA] |
CTD |
PMID:27936102 |
|
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
|
|
G |
Dagla |
diacylglycerol lipase, alpha |
increases metabolic processing |
ISO |
DAGLA protein results in increased metabolism of 1-stearoyl-2-arachidonoylglycerol |
CTD |
PMID:18657971 |
|
NCBI chr 1:206,890,635...206,947,332
Ensembl chr 1:206,890,638...206,947,232
|
|
G |
Daglb |
diacylglycerol lipase, beta |
increases metabolic processing |
ISO |
DAGLB protein results in increased metabolism of 1-stearoyl-2-arachidonoylglycerol |
CTD |
PMID:18657971 |
|
NCBI chr12:11,059,732...11,102,170
Ensembl chr12:11,059,732...11,102,154
|
|
G |
Dgke |
diacylglycerol kinase epsilon |
increases phosphorylation |
ISO |
DGKE protein results in increased phosphorylation of 1-stearoyl-2-arachidonoylglycerol |
CTD |
PMID:17455907 |
|
NCBI chr10:73,853,030...73,877,334
Ensembl chr10:73,855,583...73,877,100
|
|
G |
Ppargc1a |
PPARG coactivator 1 alpha |
increases expression |
ISO |
1-stearoyl-2-arachidonoylglycerol results in increased expression of PPARGC1A mRNA |
CTD |
PMID:23056435 |
|
NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
multiple interactions |
ISO |
1-stearoyl-2-arachidonoylglycerol inhibits the reaction [TGFB1 protein results in increased expression of COL1A1 mRNA] |
CTD |
PMID:27936102 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Trpm6 |
transient receptor potential cation channel, subfamily M, member 6 |
multiple interactions |
ISO |
TRPM6 protein affects the reaction [1-stearoyl-2-arachidonoylglycerol results in increased transport of Barium]; TRPM6 protein affects the reaction [1-stearoyl-2-arachidonoylglycerol results in increased transport of Calcium] |
CTD |
PMID:11988098 |
|
NCBI chr 1:216,136,407...216,320,523
Ensembl chr 1:216,170,038...216,320,520
|
|
|
G |
Lipc |
lipase C, hepatic type |
decreases abundance |
ISO |
LIPC gene mutant form results in decreased abundance of 1-stearoyl-2-linoleoyl-sn-glycerol |
CTD |
PMID:24777581 |
|
NCBI chr 8:71,509,633...71,635,663
Ensembl chr 8:71,509,635...71,635,464
|
|
G |
Lipg |
lipase G, endothelial type |
decreases abundance |
ISO |
LIPG gene mutant form results in decreased abundance of 1-stearoyl-2-linoleoyl-sn-glycerol |
CTD |
PMID:24777581 |
|
NCBI chr18:68,514,923...68,536,105
Ensembl chr18:68,514,923...68,536,260
|
|
|
G |
Lipc |
lipase C, hepatic type |
multiple interactions |
ISO |
[LIPC gene mutant form co-treated with LIPG gene mutant form] results in increased abundance of stearoyl alpha-lysolecithin |
CTD |
PMID:24777581 |
|
NCBI chr 8:71,509,633...71,635,663
Ensembl chr 8:71,509,635...71,635,464
|
|
G |
Lipg |
lipase G, endothelial type |
multiple interactions |
ISO |
[LIPC gene mutant form co-treated with LIPG gene mutant form] results in increased abundance of stearoyl alpha-lysolecithin |
CTD |
PMID:24777581 |
|
NCBI chr18:68,514,923...68,536,105
Ensembl chr18:68,514,923...68,536,260
|
|
|
G |
Agtr1a |
angiotensin II receptor, type 1a |
increases expression |
ISO |
Platelet Activating Factor results in increased expression of AGTR1 mRNA |
CTD |
PMID:16386258 |
|
NCBI chr17:34,173,446...34,226,892
Ensembl chr17:34,174,429...34,226,946
|
|
G |
Alox12 |
arachidonate 12-lipoxygenase, 12S type |
increases expression |
ISO |
Platelet Activating Factor results in increased expression of ALOX12 mRNA |
CTD |
PMID:16386258 |
|
NCBI chr10:54,958,263...54,970,542
Ensembl chr10:54,958,271...54,970,542
|
|
G |
Alox5 |
arachidonate 5-lipoxygenase |
multiple interactions increases expression |
ISO |
[sodium arsenite co-treated with Platelet Activating Factor co-treated with Arachidonic Acid] results in increased phosphorylation of and results in increased activity of ALOX5 protein; [zileuton results in decreased activity of ALOX5 protein] inhibits the reaction [Calcimycin results in increased abundance of Platelet Activating Factor] Platelet Activating Factor results in increased expression of ALOX5 mRNA |
CTD |
PMID:8387780 PMID:10779545 PMID:16386258 |
|
NCBI chr 4:149,531,329...149,578,696
Ensembl chr 4:149,531,515...149,578,743
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
multiple interactions increases secretion |
ISO |
Foropafant inhibits the reaction [Platelet Activating Factor results in increased secretion of CCL2 protein] |
CTD |
PMID:15149885 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccr2 |
C-C motif chemokine receptor 2 |
increases expression |
ISO |
Platelet Activating Factor results in increased expression of CCR2 mRNA |
CTD |
PMID:16386258 |
|
NCBI chr 8:123,734,465...123,742,483
Ensembl chr 8:123,734,430...123,742,100
|
|
G |
Crp |
C-reactive protein |
increases expression |
ISO |
Platelet Activating Factor results in increased expression of CRP mRNA |
CTD |
PMID:16386258 |
|
NCBI chr13:85,135,384...85,175,178
Ensembl chr13:85,124,977...85,175,178
|
|
G |
Cx3cr1 |
C-X3-C motif chemokine receptor 1 |
increases expression |
ISO |
Platelet Activating Factor results in increased expression of CX3CR1 mRNA |
CTD |
PMID:16386258 |
|
NCBI chr 8:119,785,726...119,799,431
Ensembl chr 8:119,782,595...119,800,014
|
|
G |
Edn1 |
endothelin 1 |
multiple interactions increases abundance |
EXP |
Carbon Tetrachloride promotes the reaction [EDN1 protein results in increased abundance of Platelet Activating Factor]; EDNRB protein affects the reaction [Carbon Tetrachloride promotes the reaction [EDN1 protein results in increased abundance of Platelet Activating Factor]]; EDNRB protein affects the reaction [EDN1 protein results in increased abundance of Platelet Activating Factor] |
CTD |
PMID:18205269 |
|
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
|
|
G |
Ednrb |
endothelin receptor type B |
multiple interactions |
EXP |
EDNRB protein affects the reaction [Carbon Tetrachloride promotes the reaction [EDN1 protein results in increased abundance of Platelet Activating Factor]]; EDNRB protein affects the reaction [EDN1 protein results in increased abundance of Platelet Activating Factor] |
CTD |
PMID:18205269 |
|
NCBI chr15:80,640,839...80,672,115
Ensembl chr15:80,643,043...80,672,115
|
|
G |
Egr1 |
early growth response 1 |
increases expression |
ISO |
Platelet Activating Factor results in increased expression of EGR1 mRNA |
CTD |
PMID:16386258 |
|
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
|
|
G |
Gusb |
glucuronidase, beta |
multiple interactions |
EXP |
[Platelet Activating Factor co-treated with Cytochalasin B] results in increased secretion of GUSB protein; IMMLG5521 inhibits the reaction [[Platelet Activating Factor co-treated with Cytochalasin B] results in increased secretion of GUSB protein] |
CTD |
PMID:23850278 |
|
NCBI chr12:26,701,188...26,714,718
Ensembl chr12:26,697,951...26,726,905
|
|
G |
Il1a |
interleukin 1 alpha |
increases expression |
ISO |
Platelet Activating Factor results in increased expression of IL1A mRNA |
CTD |
PMID:16386258 |
|
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Il1b |
interleukin 1 beta |
increases expression increases secretion multiple interactions |
ISO |
Platelet Activating Factor results in increased expression of IL1B mRNA Platelet Activating Factor results in increased secretion of IL1B protein [Platelet Activating Factor co-treated with MIR149 mRNA] affects the secretion of IL1B protein; PVT1 mRNA affects the reaction [Platelet Activating Factor results in increased secretion of IL1B protein] |
CTD |
PMID:16386258 PMID:32830409 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il6 |
interleukin 6 |
multiple interactions increases secretion |
ISO |
[Platelet Activating Factor co-treated with MIR149 mRNA] affects the secretion of IL6 protein; PVT1 mRNA affects the reaction [Platelet Activating Factor results in increased secretion of IL6 protein] |
CTD |
PMID:32830409 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Itgam |
integrin subunit alpha M |
multiple interactions increases expression |
ISO |
Foropafant inhibits the reaction [Platelet Activating Factor results in increased expression of ITGAM protein]; Isoproterenol promotes the reaction [Theophylline inhibits the reaction [Platelet Activating Factor results in increased expression of ITGAM protein]]; Theophylline inhibits the reaction [Platelet Activating Factor results in increased expression of ITGAM protein] |
CTD |
PMID:9762784 PMID:11116075 |
|
NCBI chr 1:182,659,047...182,709,501
Ensembl chr 1:182,659,000...182,709,503
|
|
G |
Ltb4r |
leukotriene B4 receptor |
affects response to substance |
ISO |
LTB4R1 protein affects the susceptibility to Platelet Activating Factor |
CTD |
PMID:10934231 |
|
NCBI chr15:29,263,199...29,265,716
|
|
G |
Mmp13 |
matrix metallopeptidase 13 |
increases expression |
ISO |
Platelet Activating Factor results in increased expression of MMP13 mRNA |
CTD |
PMID:16386258 |
|
NCBI chr 8:4,497,960...4,508,239
Ensembl chr 8:4,497,960...4,508,239
|
|
G |
Myd88 |
MYD88, innate immune signal transduction adaptor |
increases expression multiple interactions |
ISO |
Platelet Activating Factor results in increased expression of MYD88 protein PVT1 mRNA affects the reaction [Platelet Activating Factor results in increased expression of MYD88 protein] |
CTD |
PMID:32830409 |
|
NCBI chr 8:119,074,439...119,078,508
Ensembl chr 8:119,074,437...119,079,415
|
|
G |
Nceh1 |
neutral cholesterol ester hydrolase 1 |
multiple interactions |
ISO |
NCEH1 protein inhibits the reaction [[Chlorpyrifos metabolite co-treated with Cytidine Diphosphate Choline] results in increased abundance of Platelet Activating Factor] |
CTD |
PMID:18164358 |
|
NCBI chr 2:110,074,985...110,135,592
Ensembl chr 2:110,074,957...110,135,588
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
multiple interactions increases degradation |
ISO |
Acetylcysteine inhibits the reaction [Platelet Activating Factor results in increased degradation of NFKBIA protein]; BN 50739 inhibits the reaction [Platelet Activating Factor results in increased degradation of NFKBIA protein]; Genistein inhibits the reaction [Platelet Activating Factor results in increased degradation of NFKBIA protein]; herbimycin inhibits the reaction [Platelet Activating Factor results in increased degradation of NFKBIA protein]; pyrrolidine dithiocarbamic acid inhibits the reaction [Platelet Activating Factor results in increased degradation of NFKBIA protein]; Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Platelet Activating Factor results in increased degradation of NFKBIA protein]; Vitamin E inhibits the reaction [Platelet Activating Factor results in increased degradation of NFKBIA protein] |
CTD |
PMID:10921504 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Olr1 |
oxidized low density lipoprotein receptor 1 |
increases expression |
ISO |
Platelet Activating Factor results in increased expression of OLR1 mRNA |
CTD |
PMID:16386258 |
|
NCBI chr 4:162,926,436...162,949,057
Ensembl chr 4:162,926,439...162,948,523
|
|
G |
Pla2g7 |
phospholipase A2 group VII |
multiple interactions increases expression |
ISO |
[lipopolysaccharide, Escherichia coli O111 B4 co-treated with Platelet Activating Factor] results in increased expression of PLA2G7 mRNA; bepafant inhibits the reaction [Platelet Activating Factor results in increased expression of PLA2G7 mRNA] |
CTD |
PMID:21432021 |
|
NCBI chr 9:17,362,214...17,404,476
Ensembl chr 9:17,362,225...17,404,476
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
decreases expression |
ISO |
Platelet Activating Factor results in decreased expression of PPARA mRNA |
CTD |
PMID:16386258 |
|
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
|
|
G |
Ptafr |
platelet-activating factor receptor |
multiple interactions increases expression increases phosphorylation affects binding |
ISO EXP |
1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine inhibits the reaction [Platelet Activating Factor binds to PTAFR protein]; BN 50730 inhibits the reaction [Platelet Activating Factor binds to PTAFR protein]; BN 50739 inhibits the reaction [Platelet Activating Factor binds to PTAFR protein]; CMI 392 inhibits the reaction [Platelet Activating Factor binds to PTAFR protein]; MK 287 inhibits the reaction [Platelet Activating Factor binds to PTAFR protein]; zileuton inhibits the reaction [Platelet Activating Factor binds to PTAFR protein] Platelet Activating Factor results in increased expression of PTAFR mRNA Platelet Activating Factor results in increased phosphorylation of PTAFR protein bepafant inhibits the reaction [Platelet Activating Factor results in increased expression of PTAFR mRNA]; Carbon Tetrachloride promotes the reaction [Platelet Activating Factor binds to PTAFR protein]; RGS4 protein inhibits the reaction [Platelet Activating Factor results in increased phosphorylation of PTAFR protein]; TNF protein affects the reaction [Platelet Activating Factor results in increased expression of PTAFR mRNA] |
CTD |
PMID:9065783 PMID:10447766 PMID:11297424 PMID:11529688 PMID:16386258 PMID:18205269 More...
|
|
NCBI chr 5:144,765,770...144,795,057
Ensembl chr 5:144,765,976...144,795,251
|
|
G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
increases expression |
ISO |
Platelet Activating Factor results in increased expression of PTGS1 mRNA |
CTD |
PMID:16386258 |
|
NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
increases expression |
ISO |
Platelet Activating Factor results in increased expression of PTGS2 mRNA |
CTD |
PMID:16386258 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Pvt1 |
Pvt1 oncogene |
increases expression multiple interactions |
ISO |
Platelet Activating Factor results in increased expression of PVT1 mRNA [Platelet Activating Factor co-treated with PVT1 mRNA] affects the expression of MIR149 mRNA; PVT1 mRNA affects the reaction [Platelet Activating Factor results in increased expression of MYD88 protein]; PVT1 mRNA affects the reaction [Platelet Activating Factor results in increased secretion of IL1B protein]; PVT1 mRNA affects the reaction [Platelet Activating Factor results in increased secretion of IL6 protein]; PVT1 mRNA affects the reaction [Platelet Activating Factor results in increased secretion of TNF protein] |
CTD |
PMID:32830409 |
|
NCBI chr 7:93,656,528...93,879,938
|
|
G |
Rgs4 |
regulator of G-protein signaling 4 |
multiple interactions |
EXP |
RGS4 protein inhibits the reaction [Platelet Activating Factor results in increased phosphorylation of PTAFR protein] |
CTD |
PMID:11297424 |
|
NCBI chr13:81,936,775...81,943,103
Ensembl chr13:81,936,775...81,943,068
|
|
G |
Sele |
selectin E |
increases expression |
ISO |
Platelet Activating Factor results in increased expression of SELE mRNA |
CTD |
PMID:16386258 |
|
NCBI chr13:76,402,841...76,412,741
Ensembl chr13:76,403,304...76,412,741
|
|
G |
Sell |
selectin L |
multiple interactions increases secretion |
ISO |
Isoproterenol promotes the reaction [Theophylline inhibits the reaction [Platelet Activating Factor results in increased secretion of SELL protein]]; Theophylline inhibits the reaction [Platelet Activating Factor results in increased secretion of SELL protein] |
CTD |
PMID:9762784 |
|
NCBI chr13:76,416,969...76,436,444
Ensembl chr13:76,416,915...76,436,456
|
|
G |
Selp |
selectin P |
multiple interactions increases expression |
ISO |
Foropafant inhibits the reaction [Platelet Activating Factor results in increased expression of SELP protein] |
CTD |
PMID:11116075 |
|
NCBI chr13:76,476,229...76,511,846
Ensembl chr13:76,476,295...76,511,845
|
|
G |
Timp4 |
TIMP metallopeptidase inhibitor 4 |
increases expression |
ISO |
Platelet Activating Factor results in increased expression of TIMP4 mRNA |
CTD |
PMID:16386258 |
|
NCBI chr 4:148,306,021...148,312,558
Ensembl chr 4:148,304,490...148,312,558
|
|
G |
Tnf |
tumor necrosis factor |
increases secretion multiple interactions increases expression |
ISO EXP |
Platelet Activating Factor results in increased secretion of TNF protein [Platelet Activating Factor co-treated with MIR149 mRNA] affects the secretion of TNF protein; PVT1 mRNA affects the reaction [Platelet Activating Factor results in increased secretion of TNF protein] TNF protein affects the reaction [Platelet Activating Factor results in increased expression of PTAFR mRNA] Platelet Activating Factor results in increased expression of TNF mRNA Acetylcysteine inhibits the reaction [Platelet Activating Factor results in increased expression of TNF mRNA]; BN 50739 inhibits the reaction [Platelet Activating Factor results in increased expression of TNF mRNA]; pyrrolidine dithiocarbamic acid inhibits the reaction [Platelet Activating Factor results in increased expression of TNF mRNA]; Vitamin E inhibits the reaction [Platelet Activating Factor results in increased expression of TNF mRNA] |
CTD |
PMID:9065783 PMID:10921504 PMID:16386258 PMID:32830409 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
|
G |
Abhd12 |
abhydrolase domain containing 12, lysophospholipase |
increases hydrolysis |
ISO |
ABHD12 protein results in increased hydrolysis of glyceryl 2-arachidonate |
CTD |
PMID:18096503 |
|
NCBI chr 3:139,659,315...139,719,529
Ensembl chr 3:139,659,317...139,719,564
|
|
G |
Abhd6 |
abhydrolase domain containing 6, acylglycerol lipase |
increases hydrolysis |
ISO |
ABHD6 protein results in increased hydrolysis of glyceryl 2-arachidonate |
CTD |
PMID:18096503 |
|
NCBI chr15:16,859,740...16,907,094
Ensembl chr15:16,859,738...16,906,985
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
increases expression multiple interactions |
EXP |
glyceryl 2-arachidonate results in increased expression of ACTA2 mRNA Acetaldehyde promotes the reaction [glyceryl 2-arachidonate results in increased expression of ACTA2 mRNA] |
CTD |
PMID:21863215 |
|
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Apoe |
apolipoprotein E |
multiple interactions |
ISO |
[[APOE protein affects the susceptibility to [Cholesterol, Dietary co-treated with Dietary Fats]] which affects the susceptibility to JZL 184] which affects the abundance of glyceryl 2-arachidonate |
CTD |
PMID:29813086 |
|
NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
|
|
G |
Arrb1 |
arrestin, beta 1 |
multiple interactions |
ISO |
glyceryl 2-arachidonate affects the reaction [CNR1 protein affects the localization of ARRB1 protein]; glyceryl 2-arachidonate promotes the reaction [CNR2 protein affects the localization of ARRB1 protein]; GRK2 protein promotes the reaction [glyceryl 2-arachidonate affects the reaction [CNR1 protein affects the localization of ARRB1 protein]] |
CTD |
PMID:31024316 |
|
NCBI chr 1:153,837,964...153,912,111
Ensembl chr 1:153,838,078...153,904,061
|
|
G |
Arrb2 |
arrestin, beta 2 |
multiple interactions |
ISO |
[GRK2 protein co-treated with glyceryl 2-arachidonate] affects the reaction [CNR1 protein affects the localization of ARRB2 protein]; [GRK2 protein co-treated with glyceryl 2-arachidonate] promotes the reaction [CNR2 protein affects the localization of ARRB2 protein]; glyceryl 2-arachidonate promotes the reaction [CNR1 protein affects the localization of ARRB2 protein]; glyceryl 2-arachidonate promotes the reaction [CNR2 protein affects the localization of ARRB2 protein] |
CTD |
PMID:31024316 |
|
NCBI chr10:55,146,887...55,154,854
Ensembl chr10:55,146,818...55,154,850
|
|
G |
Atf4 |
activating transcription factor 4 |
increases expression multiple interactions |
ISO |
glyceryl 2-arachidonate results in increased expression of ATF4 mRNA iodopravadoline inhibits the reaction [glyceryl 2-arachidonate results in increased expression of ATF4 mRNA] |
CTD |
PMID:32357311 |
|
NCBI chr 7:111,804,135...111,806,457
Ensembl chr 7:111,804,183...111,806,446
|
|
G |
Btg2 |
BTG anti-proliferation factor 2 |
increases expression |
ISO |
glyceryl 2-arachidonate results in increased expression of BTG2 mRNA |
CTD |
PMID:28095641 |
|
NCBI chr13:45,531,881...45,535,642
Ensembl chr13:45,531,925...45,535,628
|
|
G |
Casp3 |
caspase 3 |
affects expression |
ISO |
glyceryl 2-arachidonate affects the expression of CASP3 mRNA |
CTD |
PMID:38462211 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
increases expression |
ISO |
glyceryl 2-arachidonate results in increased expression of CCL2 protein |
CTD |
PMID:15115777 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccr1 |
C-C motif chemokine receptor 1 |
increases expression |
ISO |
glyceryl 2-arachidonate results in increased expression of CCR1 mRNA |
CTD |
PMID:29813086 |
|
NCBI chr 8:123,556,286...123,561,841
|
|
G |
Cd36 |
CD36 molecule |
increases expression |
ISO |
glyceryl 2-arachidonate results in increased expression of CD36 mRNA |
CTD |
PMID:29813086 |
|
NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903
|
|
G |
Ces1d |
carboxylesterase 1D |
increases hydrolysis multiple interactions |
ISO |
CES1 protein results in increased hydrolysis of glyceryl 2-arachidonate [CES1 protein results in increased hydrolysis of glyceryl 2-arachidonate] which results in increased chemical synthesis of Arachidonic Acid |
CTD |
PMID:21049984 |
|
NCBI chr19:13,873,490...13,912,035
Ensembl chr19:13,796,623...13,912,035
|
|
G |
Ces2h |
carboxylesterase 2H |
increases hydrolysis multiple interactions |
ISO |
CES2 protein results in increased hydrolysis of glyceryl 2-arachidonate [CES2 protein results in increased hydrolysis of glyceryl 2-arachidonate] which results in increased chemical synthesis of Arachidonic Acid |
CTD |
PMID:21049984 |
|
NCBI chr19:32,974,242...32,988,842
Ensembl chr19:32,974,242...32,988,830
|
|
G |
Cnr1 |
cannabinoid receptor 1 |
multiple interactions increases expression |
ISO EXP |
[CNR1 protein affects the susceptibility to Chlorpyrifos] which affects the hydrolysis of glyceryl 2-arachidonate; CNR1 gene mutant form inhibits the reaction [glyceryl 2-arachidonate results in increased expression of CYP27A1 mRNA]; CNR1 gene mutant form inhibits the reaction [glyceryl 2-arachidonate results in increased expression of CYP7A1 mRNA]; CNR1 gene mutant form inhibits the reaction [glyceryl 2-arachidonate results in increased expression of CYP7B1 mRNA]; CNR1 gene mutant form inhibits the reaction [glyceryl 2-arachidonate results in increased expression of CYP8B1 mRNA]; CNR1 gene mutant form inhibits the reaction [glyceryl 2-arachidonate results in increased phosphorylation of and results in increased activity of MAPK1 protein]; CNR1 gene mutant form inhibits the reaction [glyceryl 2-arachidonate results in increased phosphorylation of and results in increased activity of MAPK3 protein]; CNR1 protein affects the reaction [glyceryl 2-arachidonate inhibits the reaction [Sulfur Dioxide results in increased expression of PTGS2 protein]] glyceryl 2-arachidonate results in increased expression of CNR1 mRNA [GRK2 protein co-treated with glyceryl 2-arachidonate] affects the reaction [CNR1 protein affects the localization of ARRB2 protein]; CNR1 gene mutant form inhibits the reaction [glyceryl 2-arachidonate results in increased expression of CYP27A1 mRNA]; CNR1 gene mutant form inhibits the reaction [glyceryl 2-arachidonate results in increased expression of CYP7A1 mRNA]; CNR1 gene mutant form inhibits the reaction [glyceryl 2-arachidonate results in increased expression of CYP8B1 mRNA]; glyceryl 2-arachidonate affects the reaction [CNR1 protein affects the localization of ARRB1 protein]; glyceryl 2-arachidonate promotes the reaction [CNR1 protein affects the localization of ARRB2 protein]; GRK2 protein promotes the reaction [glyceryl 2-arachidonate affects the reaction [CNR1 protein affects the localization of ARRB1 protein]] Acetaldehyde promotes the reaction [glyceryl 2-arachidonate results in increased expression of CNR1 mRNA]; Nitroglycerin affects the reaction [glyceryl 2-arachidonate affects the activity of CNR1 protein] |
CTD |
PMID:12657697 PMID:15899896 PMID:16775503 PMID:21863215 PMID:23894352 PMID:26209559 PMID:28095641 PMID:31024316 PMID:36858108 More...
|
|
NCBI chr 5:48,408,543...48,436,099
Ensembl chr 5:48,408,574...48,435,099
|
|
G |
Cnr2 |
cannabinoid receptor 2 |
multiple interactions affects response to substance |
ISO |
[GRK2 protein co-treated with glyceryl 2-arachidonate] promotes the reaction [CNR2 protein affects the localization of ARRB2 protein]; [SR 144528 binds to and results in increased activity of CNR2 protein] inhibits the reaction [glyceryl 2-arachidonate results in increased expression of CXCL8 protein]; CNR2 protein affects the reaction [glyceryl 2-arachidonate results in increased expression of CXCL8 protein]; CNR2 protein affects the reaction [glyceryl 2-arachidonate results in increased transport of Calcium]; glyceryl 2-arachidonate binds to and results in increased activity of CNR2 protein; glyceryl 2-arachidonate promotes the reaction [CNR2 protein affects the localization of ARRB1 protein]; glyceryl 2-arachidonate promotes the reaction [CNR2 protein affects the localization of ARRB2 protein]; Pertussis Toxin inhibits the reaction [CNR2 protein affects the reaction [glyceryl 2-arachidonate results in increased transport of Calcium]]; SR 144528 inhibits the reaction [CNR2 protein affects the reaction [glyceryl 2-arachidonate results in increased transport of Calcium]] CNR2 gene SNP affects the susceptibility to glyceryl 2-arachidonate |
CTD |
PMID:10617657 PMID:15115777 PMID:20124950 PMID:27194477 PMID:30102254 PMID:31024316 More...
|
|
NCBI chr 5:148,125,222...148,151,548
Ensembl chr 5:148,125,604...148,151,548
|
|
G |
Creb3l3 |
cAMP responsive element binding protein 3-like 3 |
multiple interactions increases expression |
ISO |
glyceryl 2-arachidonate promotes the reaction [CREB3L3 protein binds to CYP27A1 promoter]; glyceryl 2-arachidonate promotes the reaction [CREB3L3 protein binds to CYP7A1 promoter]; INS protein inhibits the reaction [glyceryl 2-arachidonate promotes the reaction [CREB3L3 protein binds to CYP27A1 promoter]]; INS protein inhibits the reaction [glyceryl 2-arachidonate promotes the reaction [CREB3L3 protein binds to CYP7A1 promoter]]; INS protein inhibits the reaction [glyceryl 2-arachidonate results in increased expression of CREB3L3 mRNA] |
CTD |
PMID:23894352 |
|
NCBI chr 7:8,622,614...8,631,053
Ensembl chr 7:8,622,614...8,631,048
|
|
G |
Crh |
corticotropin releasing hormone |
increases abundance |
ISO |
CRH protein results in increased abundance of glyceryl 2-arachidonate |
CTD |
PMID:26821211 |
|
NCBI chr 2:102,143,055...102,144,919
Ensembl chr 2:102,143,055...102,144,919
|
|
G |
Cyp27a1 |
cytochrome P450, family 27, subfamily a, polypeptide 1 |
multiple interactions increases expression |
ISO |
CNR1 gene mutant form inhibits the reaction [glyceryl 2-arachidonate results in increased expression of CYP27A1 mRNA]; glyceryl 2-arachidonate promotes the reaction [CREB3L3 protein binds to CYP27A1 promoter]; INS protein inhibits the reaction [glyceryl 2-arachidonate promotes the reaction [CREB3L3 protein binds to CYP27A1 promoter]]; INS protein inhibits the reaction [glyceryl 2-arachidonate results in increased expression of CYP27A1 mRNA] |
CTD |
PMID:23894352 PMID:28095641 |
|
NCBI chr 9:76,264,655...76,294,551
Ensembl chr 9:76,264,860...76,294,551
|
|
G |
Cyp7a1 |
cytochrome P450 family 7 subfamily A member 1 |
multiple interactions increases expression |
ISO |
CNR1 gene mutant form inhibits the reaction [glyceryl 2-arachidonate results in increased expression of CYP7A1 mRNA]; glyceryl 2-arachidonate promotes the reaction [CREB3L3 protein binds to CYP7A1 promoter]; INS protein inhibits the reaction [glyceryl 2-arachidonate promotes the reaction [CREB3L3 protein binds to CYP7A1 promoter]]; INS protein inhibits the reaction [glyceryl 2-arachidonate results in increased expression of CYP7A1 mRNA] |
CTD |
PMID:23894352 PMID:28095641 |
|
NCBI chr 5:19,376,979...19,386,676
Ensembl chr 5:19,376,974...19,386,688
|
|
G |
Cyp7b1 |
cytochrome P450 family 7 subfamily B member 1 |
increases expression multiple interactions |
ISO |
glyceryl 2-arachidonate results in increased expression of CYP7B1 mRNA CNR1 gene mutant form inhibits the reaction [glyceryl 2-arachidonate results in increased expression of CYP7B1 mRNA] |
CTD |
PMID:23894352 |
|
NCBI chr 2:100,502,791...100,669,713
Ensembl chr 2:100,502,791...100,669,698
|
|
G |
Cyp8b1 |
cytochrome P450 family 8 subfamily B member 1 |
increases expression multiple interactions |
ISO |
glyceryl 2-arachidonate results in increased expression of CYP8B1 mRNA CNR1 gene mutant form inhibits the reaction [glyceryl 2-arachidonate results in increased expression of CYP8B1 mRNA] |
CTD |
PMID:23894352 PMID:28095641 |
|
NCBI chr 8:121,578,123...121,580,093
Ensembl chr 8:121,557,062...121,580,166
|
|
G |
Dagla |
diacylglycerol lipase, alpha |
multiple interactions |
ISO |
1-((fluoro(methyl)phosphoryl)oxy)-3-isopropoxypropan-2-yl oleate inhibits the reaction [DAGLA protein modified form results in increased chemical synthesis of glyceryl 2-arachidonate] |
CTD |
PMID:27071101 |
|
NCBI chr 1:206,890,635...206,947,332
Ensembl chr 1:206,890,638...206,947,232
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
increases expression multiple interactions |
ISO |
glyceryl 2-arachidonate results in increased expression of DDIT3 mRNA; glyceryl 2-arachidonate results in increased expression of DDIT3 protein iodopravadoline inhibits the reaction [glyceryl 2-arachidonate results in increased expression of DDIT3 mRNA]; iodopravadoline inhibits the reaction [glyceryl 2-arachidonate results in increased expression of DDIT3 protein] |
CTD |
PMID:29441458 PMID:32357311 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Egf |
epidermal growth factor |
affects expression |
ISO |
glyceryl 2-arachidonate affects the expression of EGF mRNA; glyceryl 2-arachidonate affects the expression of EGF protein |
CTD |
PMID:38462211 |
|
NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064
|
|
G |
Eif2s1 |
eukaryotic translation initiation factor 2 subunit alpha |
multiple interactions increases phosphorylation |
ISO |
GSK2656157 inhibits the reaction [glyceryl 2-arachidonate results in increased phosphorylation of EIF2S1 protein]; iodopravadoline inhibits the reaction [glyceryl 2-arachidonate results in increased phosphorylation of EIF2S1 protein] |
CTD |
PMID:32357311 |
|
NCBI chr 6:97,672,829...97,697,499
Ensembl chr 6:97,672,766...97,706,225
|
|
G |
Esrrg |
estrogen-related receptor gamma |
increases abundance |
ISO |
ESRRG protein results in increased abundance of glyceryl 2-arachidonate |
CTD |
PMID:31912162 |
|
NCBI chr13:99,167,656...99,788,016
Ensembl chr13:99,564,669...99,783,397
|
|
G |
Fabp1 |
fatty acid binding protein 1 |
affects abundance multiple interactions |
ISO |
FABP1 protein affects the abundance of glyceryl 2-arachidonate FABP1 protein affects the reaction [Dronabinol results in increased abundance of glyceryl 2-arachidonate]; FABP1 protein affects the reaction [glyceryl 2-arachidonate results in increased abundance of anandamide] |
CTD |
PMID:29414765 |
|
NCBI chr 4:103,191,015...103,194,791
Ensembl chr 4:103,191,006...103,194,788
|
|
G |
Fgf1 |
fibroblast growth factor 1 |
affects expression |
ISO |
glyceryl 2-arachidonate affects the expression of FGF1 mRNA |
CTD |
PMID:38462211 |
|
NCBI chr18:30,686,555...30,772,667
Ensembl chr18:30,686,581...30,772,357
|
|
G |
Fmr1 |
fragile X messenger ribonucleoprotein 1 |
multiple interactions |
ISO |
[FMR1 gene mutant form results in increased activity of MGLL] which results in increased degradation of glyceryl 2-arachidonate |
CTD |
PMID:20393458 |
|
NCBI chr X:147,240,239...147,278,057
Ensembl chr X:147,240,301...147,278,050
|
|
G |
Fyn |
FYN proto-oncogene, Src family tyrosine kinase |
multiple interactions |
EXP |
FYN gene mutant form inhibits the reaction [glyceryl 2-arachidonate results in increased phosphorylation of and results in increased activity of MAPK1 protein]; FYN gene mutant form inhibits the reaction [glyceryl 2-arachidonate results in increased phosphorylation of and results in increased activity of MAPK3 protein] |
CTD |
PMID:12657697 |
|
NCBI chr20:42,767,733...42,960,903
Ensembl chr20:42,766,369...42,959,911
|
|
G |
Gdnf |
glial cell derived neurotrophic factor |
affects expression |
ISO |
glyceryl 2-arachidonate affects the expression of GDNF mRNA; glyceryl 2-arachidonate affects the expression of GDNF protein |
CTD |
PMID:38462211 |
|
NCBI chr 2:56,894,022...56,919,935
Ensembl chr 2:56,895,010...56,917,209
|
|
G |
Grk2 |
G protein-coupled receptor kinase 2 |
multiple interactions |
ISO |
[GRK2 protein co-treated with glyceryl 2-arachidonate] affects the reaction [CNR1 protein affects the localization of ARRB2 protein]; [GRK2 protein co-treated with glyceryl 2-arachidonate] promotes the reaction [CNR2 protein affects the localization of ARRB2 protein]; GRK2 protein promotes the reaction [glyceryl 2-arachidonate affects the reaction [CNR1 protein affects the localization of ARRB1 protein]] |
CTD |
PMID:31024316 |
|
NCBI chr 1:201,580,823...201,601,580
Ensembl chr 1:201,581,480...201,601,582
|
|
G |
Hcrt |
hypocretin neuropeptide precursor |
increases chemical synthesis multiple interactions |
ISO |
HCRT protein modified form results in increased chemical synthesis of glyceryl 2-arachidonate 1-(2-methylbenzoxazol-6-yl)-3-(1,5)naphthyridin-4-yl urea inhibits the reaction [HCRT protein modified form results in increased chemical synthesis of glyceryl 2-arachidonate] |
CTD |
PMID:27071101 |
|
NCBI chr10:85,689,979...85,691,214
Ensembl chr10:85,689,465...85,691,210
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
increases expression |
ISO |
glyceryl 2-arachidonate results in increased expression of HSPA5 mRNA |
CTD |
PMID:32357311 |
|
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
increases expression |
ISO |
glyceryl 2-arachidonate results in increased expression of ICAM1 mRNA |
CTD |
PMID:29813086 |
|
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Il1b |
interleukin 1 beta |
decreases expression multiple interactions |
ISO |
glyceryl 2-arachidonate results in decreased expression of IL1B mRNA glyceryl 2-arachidonate inhibits the reaction [Serotonin promotes the reaction [Dextran Sulfate results in increased expression of IL1B protein]] |
CTD |
PMID:16364651 PMID:30611738 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il2 |
interleukin 2 |
multiple interactions |
ISO |
glyceryl 2-arachidonate metabolite inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcium Ionophores] results in increased secretion of IL2 protein]; T 0070907 inhibits the reaction [glyceryl 2-arachidonate metabolite inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcium Ionophores] results in increased secretion of IL2 protein]] |
CTD |
PMID:21511917 |
|
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
|
|
G |
Il6 |
interleukin 6 |
decreases expression multiple interactions |
ISO |
glyceryl 2-arachidonate results in decreased expression of IL6 mRNA glyceryl 2-arachidonate inhibits the reaction [Serotonin promotes the reaction [Dextran Sulfate results in increased expression of IL6 protein]] |
CTD |
PMID:16364651 PMID:30611738 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Ins1 |
insulin 1 |
multiple interactions |
EXP |
glyceryl 2-arachidonate promotes the reaction [INS1 protein results in increased uptake of Deoxyglucose]; N-(3-methoxyphenyl)-4-chlorocinnamanilide inhibits the reaction [glyceryl 2-arachidonate promotes the reaction [INS1 protein results in increased uptake of Deoxyglucose]] |
CTD |
PMID:31408376 |
|
NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:251,244,973...251,245,536
|
|
G |
Ins2 |
insulin 2 |
multiple interactions |
ISO |
INS protein inhibits the reaction [glyceryl 2-arachidonate promotes the reaction [CREB3L3 protein binds to CYP27A1 promoter]]; INS protein inhibits the reaction [glyceryl 2-arachidonate promotes the reaction [CREB3L3 protein binds to CYP7A1 promoter]]; INS protein inhibits the reaction [glyceryl 2-arachidonate results in increased expression of CREB3L3 mRNA]; INS protein inhibits the reaction [glyceryl 2-arachidonate results in increased expression of CYP27A1 mRNA]; INS protein inhibits the reaction [glyceryl 2-arachidonate results in increased expression of CYP7A1 mRNA] |
CTD |
PMID:23894352 |
|
NCBI chr 1:197,843,277...197,992,522
Ensembl chr 1:197,843,281...197,864,775
|
|
G |
Lep |
leptin |
multiple interactions |
ISO |
[Dietary Fats co-treated with LEP protein] results in increased chemical synthesis of glyceryl 2-arachidonate |
CTD |
PMID:27071101 |
|
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
|
|
G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
multiple interactions |
EXP |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [glyceryl 2-arachidonate results in increased phosphorylation of and results in increased activity of MAP2K1 protein]; glyceryl 2-arachidonate results in increased phosphorylation of and results in increased activity of MAP2K1 protein; U 0126 inhibits the reaction [glyceryl 2-arachidonate results in increased phosphorylation of and results in increased activity of MAP2K1 protein] |
CTD |
PMID:12657697 |
|
NCBI chr 8:64,683,449...64,754,900
Ensembl chr 8:64,683,449...64,755,147
|
|
G |
Map2k2 |
mitogen activated protein kinase kinase 2 |
multiple interactions |
EXP |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [glyceryl 2-arachidonate results in increased phosphorylation of and results in increased activity of MAP2K2 protein]; glyceryl 2-arachidonate results in increased phosphorylation of and results in increased activity of MAP2K2 protein; U 0126 inhibits the reaction [glyceryl 2-arachidonate results in increased phosphorylation of and results in increased activity of MAP2K2 protein] |
CTD |
PMID:12657697 |
|
NCBI chr 7:8,590,729...8,610,279
Ensembl chr 7:8,580,905...8,610,243
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions decreases phosphorylation |
ISO EXP |
CNR1 gene mutant form inhibits the reaction [glyceryl 2-arachidonate results in increased phosphorylation of and results in increased activity of MAPK1 protein]; glyceryl 2-arachidonate results in increased phosphorylation of and results in increased activity of MAPK1 protein glyceryl 2-arachidonate results in decreased phosphorylation of MAPK1 protein 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [glyceryl 2-arachidonate results in increased phosphorylation of and results in increased activity of MAPK1 protein]; FYN gene mutant form inhibits the reaction [glyceryl 2-arachidonate results in increased phosphorylation of and results in increased activity of MAPK1 protein]; glyceryl 2-arachidonate results in increased phosphorylation of and results in increased activity of MAPK1 protein; Rimonabant inhibits the reaction [glyceryl 2-arachidonate results in decreased phosphorylation of MAPK1 protein]; Rimonabant inhibits the reaction [glyceryl 2-arachidonate results in increased phosphorylation of and results in increased activity of MAPK1 protein] |
CTD |
PMID:12657697 PMID:31917333 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions decreases phosphorylation |
ISO EXP |
CNR1 gene mutant form inhibits the reaction [glyceryl 2-arachidonate results in increased phosphorylation of and results in increased activity of MAPK3 protein]; glyceryl 2-arachidonate results in increased phosphorylation of and results in increased activity of MAPK3 protein glyceryl 2-arachidonate results in decreased phosphorylation of MAPK3 protein 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [glyceryl 2-arachidonate results in increased phosphorylation of and results in increased activity of MAPK3 protein]; FYN gene mutant form inhibits the reaction [glyceryl 2-arachidonate results in increased phosphorylation of and results in increased activity of MAPK3 protein]; glyceryl 2-arachidonate results in increased phosphorylation of and results in increased activity of MAPK3 protein; Rimonabant inhibits the reaction [glyceryl 2-arachidonate results in decreased phosphorylation of MAPK3 protein]; Rimonabant inhibits the reaction [glyceryl 2-arachidonate results in increased phosphorylation of and results in increased activity of MAPK3 protein] |
CTD |
PMID:12657697 PMID:31917333 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mgll |
monoglyceride lipase |
multiple interactions affects abundance increases degradation increases abundance increases hydrolysis |
EXP ISO |
[Chlorpyrifos results in decreased activity of MGLL protein] which results in increased abundance of glyceryl 2-arachidonate; JZL 184 inhibits the reaction [MGLL protein results in increased hydrolysis of glyceryl 2-arachidonate] MGLL protein affects the abundance of glyceryl 2-arachidonate MGLL protein results in increased degradation of glyceryl 2-arachidonate [FMR1 gene mutant form results in increased activity of MGLL] which results in increased degradation of glyceryl 2-arachidonate; [JZL 184 results in decreased activity of MGLL protein] which results in increased abundance of glyceryl 2-arachidonate; [MJN110 results in decreased activity of MGLL protein] which results in decreased hydrolysis of and results in increased abundance of glyceryl 2-arachidonate MGLL gene mutant form results in increased abundance of glyceryl 2-arachidonate |
CTD |
PMID:18096503 PMID:20393458 PMID:21507991 PMID:23761300 PMID:25030704 PMID:26209559 PMID:26642910 PMID:26791602 PMID:30301768 More...
|
|
NCBI chr 4:121,192,186...121,294,187
Ensembl chr 4:121,192,195...121,294,179
|
|
G |
Mpo |
myeloperoxidase |
multiple interactions |
ISO |
glyceryl 2-arachidonate inhibits the reaction [Serotonin promotes the reaction [Dextran Sulfate results in increased activity of MPO protein]] |
CTD |
PMID:30611738 |
|
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
multiple interactions increases cleavage |
ISO |
GSK2656157 inhibits the reaction [glyceryl 2-arachidonate results in increased cleavage of PARP1 protein] |
CTD |
PMID:29441458 PMID:32357311 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
affects localization multiple interactions |
EXP |
glyceryl 2-arachidonate affects the localization of PPARA protein [palmidrol co-treated with glyceryl 2-arachidonate] affects the localization of PPARA protein; [palmidrol co-treated with glyceryl 2-arachidonate] affects the reaction [lipopolysaccharide, E. coli O26-B6 affects the localization of PPARA protein]; glyceryl 2-arachidonate affects the reaction [lipopolysaccharide, E. coli O26-B6 affects the localization of PPARA protein] |
CTD |
PMID:31787870 |
|
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
affects binding multiple interactions increases expression |
ISO |
glyceryl 2-arachidonate metabolite binds to PPARG protein glyceryl 2-arachidonate inhibits the reaction [Sulfur Dioxide results in decreased expression of PPARG protein]; PPARG protein affects the reaction [glyceryl 2-arachidonate inhibits the reaction [Sulfur Dioxide results in increased expression of PTGS2 protein]]; PPARG protein affects the reaction [glyceryl 2-arachidonate inhibits the reaction [Sulfur Dioxide results in increased phosphorylation of RELA protein]] T 0070907 inhibits the reaction [glyceryl 2-arachidonate metabolite results in increased expression of PPARG mRNA] |
CTD |
PMID:21511917 PMID:26209559 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
multiple interactions |
EXP |
[Indomethacin results in decreased expression of PTGS1] which results in increased activity of glyceryl 2-arachidonate |
CTD |
PMID:17245358 |
|
NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
increases metabolic processing multiple interactions |
ISO |
PTGS2 protein results in increased metabolism of glyceryl 2-arachidonate 2-chloro-5-nitrobenzanilide inhibits the reaction [glyceryl 2-arachidonate inhibits the reaction [Sulfur Dioxide results in increased expression of PTGS2 protein]]; CNR1 protein affects the reaction [glyceryl 2-arachidonate inhibits the reaction [Sulfur Dioxide results in increased expression of PTGS2 protein]]; glyceryl 2-arachidonate inhibits the reaction [Sulfur Dioxide results in increased expression of PTGS2 protein]; PPARG protein affects the reaction [glyceryl 2-arachidonate inhibits the reaction [Sulfur Dioxide results in increased expression of PTGS2 protein]]; rimonabant inhibits the reaction [glyceryl 2-arachidonate inhibits the reaction [Sulfur Dioxide results in increased expression of PTGS2 protein]] glyceryl 2-arachidonate inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcium Ionophores] results in increased expression of PTGS2 mRNA]; Ibuprofen inhibits the reaction [PTGS2 protein results in increased metabolism of glyceryl 2-arachidonate] |
CTD |
PMID:18297109 PMID:21511917 PMID:26209559 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
2-chloro-5-nitrobenzanilide inhibits the reaction [glyceryl 2-arachidonate inhibits the reaction [Sulfur Dioxide results in increased phosphorylation of RELA protein]]; glyceryl 2-arachidonate inhibits the reaction [Sulfur Dioxide results in increased phosphorylation of RELA protein]; PPARG protein affects the reaction [glyceryl 2-arachidonate inhibits the reaction [Sulfur Dioxide results in increased phosphorylation of RELA protein]] |
CTD |
PMID:26209559 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Tnf |
tumor necrosis factor |
decreases expression multiple interactions |
ISO EXP |
glyceryl 2-arachidonate results in decreased expression of TNF mRNA glyceryl 2-arachidonate inhibits the reaction [[Serotonin co-treated with Dextran Sulfate] results in increased expression of TNF protein]; glyceryl 2-arachidonate inhibits the reaction [amyloid beta-protein (25-35) results in increased expression of TNF protein] glyceryl 2-arachidonate inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased expression of TNF protein] |
CTD |
PMID:12509806 PMID:16364651 PMID:30611738 PMID:30769029 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Trpv1 |
transient receptor potential cation channel, subfamily V, member 1 |
multiple interactions affects response to substance |
EXP ISO |
glyceryl 2-arachidonate binds to and results in increased activity of TRPV1 protein TRPV1 protein affects the susceptibility to glyceryl 2-arachidonate |
CTD |
PMID:18550765 PMID:21949157 |
|
NCBI chr10:57,851,428...57,876,513
Ensembl chr10:57,851,428...57,876,513
|
|
G |
Yy1 |
YY1 transcription factor |
increases expression |
ISO |
glyceryl 2-arachidonate results in increased expression of YY1 mRNA |
CTD |
PMID:28095641 |
|
NCBI chr 6:127,706,739...127,736,499
Ensembl chr 6:127,707,596...127,732,747
|
|
|
G |
Tnf |
tumor necrosis factor |
increases expression |
EXP |
platelet-activating factor increases expression of Tnf protein in portal stenosis rat plasma |
RGD |
PMID:10452877 |
RGD:38508900 |
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
|
G |
Fabp1 |
fatty acid binding protein 1 |
affects abundance |
ISO |
FABP1 protein affects the abundance of 2-oleoylglycerol |
CTD |
PMID:29414765 |
|
NCBI chr 4:103,191,015...103,194,791
Ensembl chr 4:103,191,006...103,194,788
|
|
G |
Mgll |
monoglyceride lipase |
increases degradation multiple interactions |
EXP |
MGLL protein results in increased degradation of 2-oleoylglycerol Nitroglycerin promotes the reaction [MGLL protein results in increased degradation of 2-oleoylglycerol] |
CTD |
PMID:19515121 |
|
NCBI chr 4:121,192,186...121,294,187
Ensembl chr 4:121,192,195...121,294,179
|
|
|
G |
6430548M08Rikl |
RIKEN cDNA 6430548M08 gene like |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of KIAA0513 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr19:48,168,651...48,216,571
Ensembl chr19:48,198,209...48,216,575
|
|
G |
Aadacl3 |
arylacetamide deacetylase-like 3 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of AADACL3 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 5:156,242,182...156,252,215
Ensembl chr 5:156,243,415...156,252,205
|
|
G |
Abca1 |
ATP binding cassette subfamily A member 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ABCA1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 5:67,678,267...67,801,162
Ensembl chr 5:67,681,297...67,801,170
|
|
G |
Abca13 |
ATP binding cassette subfamily A member 13 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ABCA13 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr14:83,873,397...84,376,138
Ensembl chr14:83,873,940...84,375,075
|
|
G |
Abca8 |
ATP binding cassette subfamily A member 8 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ABCA8 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr10:94,917,520...94,991,199
Ensembl chr10:94,917,520...94,990,988
|
|
G |
Abcc4 |
ATP binding cassette subfamily C member 4 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ABCC4 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr15:95,541,186...95,774,898
Ensembl chr15:95,542,315...95,774,283
|
|
G |
Abcc9 |
ATP binding cassette subfamily C member 9 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ABCC9 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 4:175,531,854...175,655,849
Ensembl chr 4:175,532,547...175,655,356
|
|
G |
Abcd1 |
ATP binding cassette subfamily D member 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ABCD1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr X:151,428,334...151,450,115
Ensembl chr X:151,428,578...151,450,115
|
|
G |
Abcd3 |
ATP binding cassette subfamily D member 3 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ABCD3 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 2:209,852,087...209,905,763
Ensembl chr 2:209,852,087...209,906,020
|
|
G |
Abhd3 |
abhydrolase domain containing 3, phospholipase |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ABHD3 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr18:1,723,203...1,778,488
Ensembl chr18:1,720,718...1,803,428
|
|
G |
Abhd6 |
abhydrolase domain containing 6, acylglycerol lipase |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ABHD6 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr15:16,859,740...16,907,094
Ensembl chr15:16,859,738...16,906,985
|
|
G |
Abi3bp |
ABI family member 3 binding protein |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ABI3BP mRNA |
CTD |
PMID:37199045 |
|
NCBI chr11:43,912,187...44,128,888
Ensembl chr11:43,913,043...44,128,929
|
|
G |
Ablim3 |
actin binding LIM protein family, member 3 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ABLIM3 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr18:55,256,135...55,376,629
Ensembl chr18:55,257,583...55,376,380
|
|
G |
Abr |
ABR activator of RhoGEF and GTPase |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ABR mRNA |
CTD |
PMID:37199045 |
|
NCBI chr10:61,262,516...61,461,331
Ensembl chr10:61,262,516...61,461,505
|
|
G |
Abracl |
ABRA C-terminal like |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ABRACL mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 1:12,654,951...12,665,143
Ensembl chr 1:12,654,838...12,665,207
|
|
G |
Acadsb |
acyl-CoA dehydrogenase, short/branched chain |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ACADSB mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 1:186,188,939...186,227,796
Ensembl chr 1:186,188,987...186,230,379
|
|
G |
Acadvl |
acyl-CoA dehydrogenase, very long chain |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ACADVL mRNA |
CTD |
PMID:37199045 |
|
NCBI chr10:54,732,875...54,738,102
Ensembl chr10:54,732,469...54,738,075
|
|
G |
Acbd6 |
acyl-CoA binding domain containing 6 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ACBD6 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr13:67,726,786...67,863,392
Ensembl chr13:67,726,786...67,862,311
|
|
G |
Acbd7 |
acyl-CoA binding domain containing 7 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ACBD7 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr17:74,903,936...74,909,977
Ensembl chr17:74,903,177...74,905,811
|
|
G |
Acot8 |
acyl-CoA thioesterase 8 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ACOT8 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 3:153,531,192...153,542,851
Ensembl chr 3:153,531,193...153,542,851
|
|
G |
Acp3 |
acid phosphatase 3 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ACP3 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 8:104,905,570...104,956,146
Ensembl chr 8:104,905,586...104,954,236
|
|
G |
Acsl6 |
acyl-CoA synthetase long-chain family member 6 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ACSL6 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr10:38,439,914...38,501,182
Ensembl chr10:38,440,080...38,498,757
|
|
G |
Acvr1c |
activin A receptor type 1C |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ACVR1C mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 3:42,815,490...42,892,423
Ensembl chr 3:42,822,610...42,892,327
|
|
G |
Acyp1 |
acylphosphatase 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ACYP1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 6:104,919,162...104,932,348
Ensembl chr 6:104,919,162...104,932,387
|
|
G |
Adam28 |
ADAM metallopeptidase domain 28 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ADAM28 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr15:43,774,463...43,840,726
Ensembl chr15:42,944,467...43,840,672
|
|
G |
Adamts10 |
ADAM metallopeptidase with thrombospondin type 1 motif, 10 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ADAMTS10 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 7:14,331,659...14,361,620
Ensembl chr 7:14,331,745...14,361,620
|
|
G |
Adamts14 |
ADAM metallopeptidase with thrombospondin type 1 motif, 14 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ADAMTS14 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr20:29,143,029...29,219,846
Ensembl chr20:29,144,354...29,219,866
|
|
G |
Adamts2 |
ADAM metallopeptidase with thrombospondin type 1 motif, 2 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ADAMTS2 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr10:34,920,992...35,126,465
Ensembl chr10:34,921,049...35,123,821
|
|
G |
Adamts5 |
ADAM metallopeptidase with thrombospondin type 1 motif, 5 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ADAMTS5 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr11:25,000,627...25,047,205
Ensembl chr11:25,000,637...25,047,205
|
|
G |
Adamtsl1 |
ADAMTS-like 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ADAMTSL1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 5:99,964,406...100,919,786
Ensembl chr 5:99,964,486...100,918,384
|
|
G |
Adcy8 |
adenylate cyclase 8 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ADCY8 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 7:96,417,310...96,665,911
Ensembl chr 7:96,417,324...96,665,911
|
|
G |
Adcyap1 |
adenylate cyclase activating polypeptide 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ADCYAP1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 9:113,102,632...113,122,500
Ensembl chr 9:113,103,718...113,109,773
|
|
G |
Adgrf5 |
adhesion G protein-coupled receptor F5 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ADGRF5 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 9:17,517,596...17,624,107
Ensembl chr 9:17,520,009...17,623,968
|
|
G |
Adgrl4 |
adhesion G protein-coupled receptor L4 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ADGRL4 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 2:240,354,909...240,457,231
Ensembl chr 2:240,354,941...240,457,225
|
|
G |
Adh4 |
alcohol dehydrogenase 4 (class II), pi polypeptide |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ADH4 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 2:226,948,717...226,966,747
Ensembl chr 2:226,947,466...226,987,591
|
|
G |
Adm |
adrenomedullin |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ADM mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 1:164,745,484...164,747,655
Ensembl chr 1:164,745,466...164,747,654
|
|
G |
Adprh |
ADP-ribosylarginine hydrolase |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ADPRH mRNA |
CTD |
PMID:37199045 |
|
NCBI chr11:62,299,831...62,306,170
Ensembl chr11:62,299,793...62,306,931
|
|
G |
Adprs |
ADP-ribosylserine hydrolase |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ADPRS mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 5:138,614,022...138,619,296
Ensembl chr 5:138,614,022...138,619,296
|
|
G |
Adrb2 |
adrenoceptor beta 2 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ADRB2 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr18:55,642,459...55,644,501
Ensembl chr18:55,502,903...55,644,512
|
|
G |
Aggf1 |
angiogenic factor with G patch and FHA domains 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of AGGF1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 2:26,619,336...26,646,050
Ensembl chr 2:26,619,339...26,645,952
|
|
G |
Ago2 |
argonaute RISC catalytic component 2 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of AGO2 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 7:105,018,202...105,105,118
Ensembl chr 7:105,029,120...105,104,974
|
|
G |
Agtr1a |
angiotensin II receptor, type 1a |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of AGTR1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr17:34,173,446...34,226,892
Ensembl chr17:34,174,429...34,226,946
|
|
G |
Ahcy |
adenosylhomocysteinase |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of AHCY mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 3:143,569,134...143,584,359
Ensembl chr 3:143,569,094...143,584,393
|
|
G |
Ahdc1 |
AT hook, DNA binding motif, containing 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of AHDC1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 5:145,228,228...145,294,170
Ensembl chr 5:145,228,227...145,294,145
|
|
G |
Aif1 |
allograft inflammatory factor 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of AIF1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr20:3,646,784...3,652,670
Ensembl chr20:3,646,777...3,652,668
|
|
G |
Airim |
AFG2 interacting ribosome maturation factor |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of AIRIM mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 5:137,198,688...137,205,912
Ensembl chr 5:137,198,720...137,204,026
|
|
G |
Ak5 |
adenylate kinase 5 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of AK5 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 2:241,397,297...241,581,483
Ensembl chr 2:241,397,297...241,581,458
|
|
G |
Ak7 |
adenylate kinase 7 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of AK7 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 6:124,611,789...124,679,978
Ensembl chr 6:124,611,902...124,679,961
|
|
G |
Akap17a |
A-kinase anchoring protein 17A |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of AKAP17A mRNA |
CTD |
PMID:37199045 |
|
NCBI chr12:16,310,427...16,315,166
Ensembl chr12:16,310,437...16,314,479
|
|
G |
Akap8 |
A-kinase anchoring protein 8 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of AKAP8 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 7:11,316,224...11,332,523
Ensembl chr 7:11,316,228...11,332,399
|
|
G |
Akr1b1 |
aldo-keto reductase family 1 member B1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of AKR1B1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 4:62,932,033...62,946,126
Ensembl chr 4:62,932,031...62,946,157
|
|
G |
Akr1b10 |
aldo-keto reductase family 1 member B10 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of AKR1B10 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 4:63,038,459...63,060,336
Ensembl chr 4:63,040,169...63,053,852
|
|
G |
Akr1b8 |
aldo-keto reductase family 1, member B8 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of AKR1B15 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 4:62,997,241...63,009,815
Ensembl chr 4:62,997,161...63,010,097
|
|
G |
Akr1c2 |
aldo-keto reductase family 1, member C2 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of AKR1C2 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr17:65,759,778...65,808,013
Ensembl chr17:65,759,788...65,775,764
|
|
G |
Akr7a3 |
aldo-keto reductase family 7 member A3 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of AKR7A3 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 5:151,590,968...151,601,394
Ensembl chr 5:151,584,479...151,601,394
|
|
G |
Aldh1a2 |
aldehyde dehydrogenase 1 family, member A2 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ALDH1A2 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 8:71,877,850...71,957,107
Ensembl chr 8:71,877,850...71,957,107
|
|
G |
Aldh1a3 |
aldehyde dehydrogenase 1 family, member A3 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ALDH1A3 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 1:119,982,272...120,017,416
Ensembl chr 1:119,982,277...120,017,436
|
|
G |
Aldob |
aldolase, fructose-bisphosphate B |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ALDOB mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 5:63,889,045...63,902,086
Ensembl chr 5:63,889,046...63,902,116
|
|
G |
Als2cl |
ALS2 C-terminal like |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ALS2CL mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 8:110,863,753...110,884,434
Ensembl chr 8:110,864,975...110,884,419
|
|
G |
Amigo2 |
adhesion molecule with Ig like domain 2 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of AMIGO2 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 7:128,391,493...128,394,589
Ensembl chr 7:128,390,412...128,394,695
|
|
G |
Amigo3 |
adhesion molecule with Ig like domain 3 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of AMIGO3 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 8:108,741,899...108,743,425
Ensembl chr 8:108,693,060...108,744,555
|
|
G |
Ampd2 |
adenosine monophosphate deaminase 2 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of AMPD2 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 2:195,707,609...195,720,454
Ensembl chr 2:195,707,610...195,720,271
|
|
G |
Ampd3 |
adenosine monophosphate deaminase 3 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of AMPD3 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 1:164,884,823...164,929,899
Ensembl chr 1:164,885,320...164,929,887
|
|
G |
Angptl4 |
angiopoietin-like 4 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ANGPTL4 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 7:14,550,288...14,557,797
Ensembl chr 7:14,550,311...14,556,519
|
|
G |
Angptl6 |
angiopoietin-like 6 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ANGPTL6 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 8:19,413,617...19,419,925
Ensembl chr 8:19,413,619...19,419,925
|
|
G |
Ank2 |
ankyrin 2 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ANK2 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 2:215,378,028...215,954,015
Ensembl chr 2:215,379,680...215,862,923
|
|
G |
Ank3 |
ankyrin 3 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ANK3 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr20:18,602,267...19,225,831
Ensembl chr20:18,602,786...19,086,300
|
|
G |
Ankrd27 |
ankyrin repeat domain 27 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ANKRD27 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 1:88,251,216...88,303,615
Ensembl chr 1:88,251,226...88,303,615
|
|
G |
Ankrd37 |
ankyrin repeat domain 37 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ANKRD37 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr16:46,268,933...46,271,971
Ensembl chr16:46,268,443...46,271,963
|
|
G |
Ankrd44 |
ankyrin repeat domain 44 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ANKRD44 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 9:56,126,746...56,427,661
Ensembl chr 9:56,126,747...56,427,508
|
|
G |
Ankrd52 |
ankyrin repeat domain 52 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ANKRD52 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 7:806,829...820,481
Ensembl chr 7:806,767...820,481
|
|
G |
Anln |
anillin, actin binding protein |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ANLN mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 8:20,858,227...20,921,602
Ensembl chr 8:20,858,228...20,921,538
|
|
G |
Ano2 |
anoctamin 2 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ANO2 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 4:158,514,200...158,855,639
Ensembl chr 4:158,496,014...158,855,651
|
|
G |
Ano6 |
anoctamin 6 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ANO6 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 7:126,933,919...127,113,588
Ensembl chr 7:126,933,936...127,113,589
|
|
G |
Anpep |
alanyl aminopeptidase, membrane |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ANPEP mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 1:133,767,332...133,810,137
Ensembl chr 1:133,767,332...133,785,789
|
|
G |
Antkmt |
adenine nucleotide translocase lysine methyltransferase |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ANTKMT mRNA |
CTD |
PMID:37199045 |
|
NCBI chr10:14,812,274...14,814,798
Ensembl chr10:14,812,269...14,814,193
|
|
G |
Anxa10 |
annexin A10 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ANXA10 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr16:27,738,712...27,805,648
Ensembl chr16:27,738,712...27,805,648
|
|
G |
Aox1 |
aldehyde oxidase 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of AOX1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 9:59,579,621...59,658,772
Ensembl chr 9:59,579,649...59,658,770
|
|
G |
Ap1s1 |
adaptor related protein complex 1 subunit sigma 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of AP1S1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr12:19,625,267...19,635,792
Ensembl chr12:19,625,332...19,756,713
|
|
G |
Apba1 |
amyloid beta precursor protein binding family A member 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of APBA1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 1:221,363,769...221,569,496
Ensembl chr 1:221,363,778...221,566,553
|
|
G |
Apbb1ip |
amyloid beta precursor protein binding family B member 1 interacting protein |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of APBB1IP mRNA |
CTD |
PMID:37199045 |
|
NCBI chr17:84,941,404...85,033,020
Ensembl chr17:84,982,243...85,033,010
|
|
G |
Apbb2 |
amyloid beta precursor protein binding family B member 2 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of APBB2 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr14:41,557,918...41,878,622
Ensembl chr14:41,557,972...41,877,495
|
|
G |
Aph1b |
aph-1 homolog B, gamma secretase subunit |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of APH1B mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 8:67,429,198...67,454,735
Ensembl chr 8:67,429,198...67,450,243
|
|
G |
Apob |
apolipoprotein B |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of APOB mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 6:30,844,386...30,883,983
Ensembl chr 6:30,844,368...30,892,497
|
|
G |
Aqp11 |
aquaporin 11 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of AQP11 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 1:152,046,515...152,056,675
Ensembl chr 1:152,046,517...152,056,725
|
|
G |
Aqp3 |
aquaporin 3 (Gill blood group) |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of AQP3 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 5:56,239,200...56,244,718
Ensembl chr 5:56,239,201...56,244,720
|
|
G |
Arfgef3 |
ARFGEF family member 3 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ARFGEF3 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 1:13,245,578...13,404,319
Ensembl chr 1:13,244,830...13,404,084
|
|
G |
Arhgap17 |
Rho GTPase activating protein 17 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ARHGAP17 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 1:177,807,579...177,897,027
Ensembl chr 1:177,807,583...177,896,854
|
|
G |
Arhgap22 |
Rho GTPase activating protein 22 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ARHGAP22 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr16:8,473,806...8,631,552
Ensembl chr16:8,476,306...8,631,548
|
|
G |
Arhgap26 |
Rho GTPase activating protein 26 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ARHGAP26 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr18:30,835,806...31,237,945
Ensembl chr18:30,838,671...31,235,194
|
|
G |
Arhgap29 |
Rho GTPase activating protein 29 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ARHGAP29 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 2:210,060,036...210,132,572
Ensembl chr 2:210,071,199...210,132,028
|
|
G |
Arhgef10 |
Rho guanine nucleotide exchange factor 10 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ARHGEF10 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr16:74,647,147...74,738,784
Ensembl chr16:74,647,153...74,738,173
|
|
G |
Arhgef11 |
Rho guanine nucleotide exchange factor 11 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ARHGEF11 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 2:173,074,383...173,195,962
Ensembl chr 2:173,074,368...173,196,010
|
|
G |
Arhgef2 |
Rho/Rac guanine nucleotide exchange factor 2 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ARHGEF2 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 2:174,061,126...174,118,355
Ensembl chr 2:174,062,976...174,118,355
|
|
G |
Arhgef3 |
Rho guanine nucleotide exchange factor 3 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ARHGEF3 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr16:2,301,573...2,581,951
Ensembl chr16:2,300,138...2,581,945
|
|
G |
Arl4c |
ADP ribosylation factor like GTPase 4C |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ARL4C mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 9:89,300,335...89,303,770
Ensembl chr 9:89,298,005...89,304,513
|
|
G |
Armc6 |
armadillo repeat containing 6 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ARMC6 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr16:19,191,106...19,201,528
Ensembl chr16:19,191,093...19,206,047
|
|
G |
Arpc5l |
actin related protein 2/3 complex, subunit 5-like |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ARPC5L mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 3:22,758,710...22,767,520
Ensembl chr 3:22,759,876...22,767,538 Ensembl chr 9:22,759,876...22,767,538
|
|
G |
Art3 |
ADP-ribosyltransferase 3 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ART3 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr14:15,637,230...15,719,442
Ensembl chr14:15,637,237...15,665,407
|
|
G |
Asb1 |
ankyrin repeat and SOCS box-containing 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ASB1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 9:92,120,332...92,140,790
Ensembl chr 9:92,120,306...92,136,376
|
|
G |
Ascl2 |
achaete-scute family bHLH transcription factor 2 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ASCL2 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 1:198,148,999...198,151,406
Ensembl chr 1:198,148,999...198,151,406
|
|
G |
Aspm |
assembly factor for spindle microtubules |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ASPM mRNA |
CTD |
PMID:37199045 |
|
NCBI chr13:51,074,849...51,123,755
Ensembl chr13:51,074,849...51,123,755
|
|
G |
Atad2 |
ATPase family, AAA domain containing 2 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ATAD2 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 7:89,634,123...89,676,738
Ensembl chr 7:89,634,123...89,676,738
|
|
G |
Atad5 |
ATPase family, AAA domain containing 5 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ATAD5 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr10:65,070,682...65,118,489
Ensembl chr10:65,070,689...65,117,845
|
|
G |
Atf3 |
activating transcription factor 3 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ATF3 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
|
|
G |
Atg16l1 |
autophagy related 16-like 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ATG16L1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 9:88,420,737...88,457,530
Ensembl chr 9:88,422,038...88,457,529
|
|
G |
Atg4b |
autophagy related 4B, cysteine peptidase |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ATG4B mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 9:94,282,417...94,314,109
Ensembl chr 9:94,282,509...94,314,103
|
|
G |
Atic |
5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ATIC mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 9:73,164,846...73,184,897
Ensembl chr 9:73,164,846...73,184,889
|
|
G |
Atp10d |
ATPase phospholipid transporting 10D (putative) |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ATP10D mRNA |
CTD |
PMID:37199045 |
|
NCBI chr14:35,911,728...36,012,549
Ensembl chr14:35,912,141...36,012,564
|
|
G |
Atp13a2 |
ATPase cation transporting 13A2 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ATP13A2 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 5:153,292,722...153,312,143
Ensembl chr 5:153,292,751...153,312,139
|
|
G |
Atp13a3 |
ATPase 13A3 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ATP13A3 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr11:70,364,998...70,442,005
Ensembl chr11:70,365,322...70,441,235
|
|
G |
Atp1a1 |
ATPase Na+/K+ transporting subunit alpha 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ATP1A1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 2:189,020,722...189,048,826
Ensembl chr 2:189,020,722...189,048,837
|
|
G |
Atp2b1 |
ATPase plasma membrane Ca2+ transporting 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ATP2B1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 7:33,735,595...33,845,226
Ensembl chr 7:33,735,871...33,843,295
|
|
G |
Atp8a1 |
ATPase phospholipid transporting 8A1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ATP8A1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr14:40,315,013...40,557,572
Ensembl chr14:40,315,049...40,554,611
|
|
G |
Atr |
ATR serine/threonine kinase |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ATR mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 8:96,426,704...96,524,152
Ensembl chr 8:96,426,724...96,524,136
|
|
G |
Aurka |
aurora kinase A |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of AURKA mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 3:161,128,309...161,144,524
Ensembl chr 3:161,128,313...161,144,390
|
|
G |
Aurkb |
aurora kinase B |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of AURKB mRNA |
CTD |
PMID:37199045 |
|
NCBI chr10:53,744,290...53,750,831
Ensembl chr10:53,745,142...53,750,837
|
|
G |
Avil |
advillin |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of AVIL mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 7:62,825,459...62,844,103
Ensembl chr 7:62,826,025...62,844,071
|
|
G |
Axl |
Axl receptor tyrosine kinase |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of AXL mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 1:81,265,088...81,296,278
Ensembl chr 1:81,265,088...81,296,265
|
|
G |
B3gat1 |
beta-1,3-glucuronyltransferase 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of B3GAT1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 8:25,087,123...25,114,692
Ensembl chr 8:25,087,547...25,113,395
|
|
G |
B4galnt4 |
beta-1,4-N-acetyl-galactosaminyl transferase 4 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of B4GALNT4 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 1:196,171,394...196,182,294
Ensembl chr 1:196,171,394...196,182,294
|
|
G |
B4galt6 |
beta-1,4-galactosyltransferase 6 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of B4GALT6 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr18:11,958,382...12,015,247
Ensembl chr18:11,958,390...12,015,247
|
|
G |
Bahd1 |
bromo adjacent homology domain containing 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of BAHD1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 3:105,891,207...105,914,414
Ensembl chr 3:105,892,478...105,914,410
|
|
G |
Bbx |
BBX high mobility group box domain containing |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of BBX mRNA |
CTD |
PMID:37199045 |
|
NCBI chr11:50,381,249...50,628,934
Ensembl chr11:50,381,247...50,623,251
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of BCL2L1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
|
|
G |
Bcl2l11 |
Bcl2-like 11 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of BCL2L11 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 3:115,366,783...115,404,068
Ensembl chr 3:115,366,646...115,404,068
|
|
G |
Bcl2l14 |
Bcl2-like 14 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of BCL2L14 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 4:167,217,561...167,258,723
Ensembl chr 4:167,219,871...167,258,086
|
|
G |
Bcl2l15 |
Bcl2-like 15 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of BCL2L15 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 2:191,338,959...191,344,078
Ensembl chr 2:191,338,959...191,344,078
|
|
G |
Bcr |
BCR activator of RhoGEF and GTPase |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of BCR mRNA |
CTD |
PMID:37199045 |
|
NCBI chr20:13,469,325...13,596,942
Ensembl chr20:13,471,668...13,597,016
|
|
G |
Bdh1 |
3-hydroxybutyrate dehydrogenase 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of BDH1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr11:69,302,534...69,343,173
Ensembl chr11:69,302,534...69,337,671
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of BDNF mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
|
|
G |
Bean1 |
brain expressed, associated with NEDD4, 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of BEAN1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr19:739,551...786,395
Ensembl chr19:739,551...787,537
|
|
G |
Bin1 |
bridging integrator 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of BIN1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr18:24,009,731...24,067,267
Ensembl chr18:24,009,653...24,067,263
|
|
G |
Birc6 |
baculoviral IAP repeat-containing 6 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of BIRC6 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 6:20,722,922...20,916,396
Ensembl chr 6:20,722,922...20,916,434
|
|
G |
Bles03 |
basophilic leukemia expressed protein BLES03 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of C11ORF68 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 1:202,734,555...202,736,809
Ensembl chr 1:202,734,555...202,736,804
|
|
G |
Blnk |
B-cell linker |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of BLNK mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 1:239,753,640...239,821,113
Ensembl chr 1:239,753,648...239,821,113
|
|
G |
Bmper |
BMP-binding endothelial regulator |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of BMPER mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 8:21,732,225...21,977,261
Ensembl chr 8:21,732,225...21,977,256
|
|
G |
Bnc1 |
basonuclin zinc finger protein 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of BNC1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 1:135,917,676...135,943,333
Ensembl chr 1:135,917,687...135,943,333
|
|
G |
Brca2 |
BRCA2, DNA repair associated |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of BRCA2 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr12:59,492...103,789
Ensembl chr12:59,819...100,567
|
|
G |
Brd1 |
bromodomain containing 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of BRD1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 7:119,774,187...119,822,032
Ensembl chr 7:119,774,188...119,822,031
|
|
G |
Brinp2 |
BMP/retinoic acid inducible neural specific 2 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of BRINP2 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr13:70,431,006...70,532,766
Ensembl chr13:70,431,010...70,531,810
|
|
G |
Brpf1 |
bromodomain and PHD finger containing, 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of BRPF1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 4:146,456,325...146,472,781
Ensembl chr 4:146,456,318...146,472,649
|
|
G |
Btbd17 |
BTB domain containing 17 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of BTBD17 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr10:99,826,132...99,832,624
Ensembl chr10:99,826,132...99,832,624
|
|
G |
Btbd18 |
BTB domain containing 18 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of BTBD18 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 3:69,743,057...69,751,096
Ensembl chr 3:69,745,012...69,751,042
|
|
G |
Btbd8 |
BTB domain containing 8 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of BTBD8 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr14:2,265,187...2,338,426
Ensembl chr14:2,266,454...2,334,393
|
|
G |
Btc |
betacellulin |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of BTC mRNA |
CTD |
PMID:37199045 |
|
NCBI chr14:16,708,447...16,746,961
Ensembl chr14:16,707,982...16,747,049
|
|
G |
Btg2 |
BTG anti-proliferation factor 2 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of BTG2 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr13:45,531,881...45,535,642
Ensembl chr13:45,531,925...45,535,628
|
|
G |
Bub1 |
BUB1 mitotic checkpoint serine/threonine kinase |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of BUB1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 3:115,020,254...115,051,650
Ensembl chr 3:115,020,254...115,051,650
|
|
G |
Bub1b |
BUB1 mitotic checkpoint serine/threonine kinase B |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of BUB1B mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 3:105,563,089...105,615,547
Ensembl chr 3:105,563,138...105,615,547
|
|
G |
Bud31 |
BUD31 homolog |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of BUD31 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr12:9,462,838...9,470,387
Ensembl chr12:9,462,441...9,470,509
|
|
G |
Bzw2 |
basic leucine zipper and W2 domains 2 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of BZW2 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 6:52,828,069...52,888,599
Ensembl chr 6:52,827,661...52,888,628
|
|
G |
C10h17orf58 |
similar to human chromosome 17 open reading frame 58 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of C17ORF58 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr10:91,972,938...91,977,606
Ensembl chr10:91,972,410...91,977,602
|
|
G |
C10h1orf35 |
similar to human chromosome 1 open reading frame 35 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of C1ORF35 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr10:43,993,809...43,997,287
Ensembl chr10:43,993,668...43,997,289
|
|
G |
C13h1orf105 |
similar to human chromosome 1 open reading frame 105 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of C1ORF105 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr13:74,313,320...74,356,322
Ensembl chr13:74,313,322...74,356,322
|
|
G |
C18h18orf21 |
similar to human chromosome 18 open reading frame 21 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of C18ORF21 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr18:15,779,349...15,786,772
Ensembl chr18:15,779,368...15,787,894
|
|
G |
C18h18orf54 |
similar to human chromosome 18 open reading frame 54 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of C18ORF54 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr18:64,065,125...64,090,260
Ensembl chr18:64,065,740...64,089,415
|
|
G |
C18h18orf63 |
similar to human chromosome 18 open reading frame 63 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of C18ORF63 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr18:78,159,334...78,202,317
Ensembl chr18:78,164,661...78,202,326
|
|
G |
C1h19orf12 |
similar to human chromosome 19 open reading frame 12 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of C19ORF12 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 1:90,873,578...90,887,205
Ensembl chr 1:90,873,549...90,886,208
|
|
G |
C2h1orf52 |
similar to human chromosome 1 open reading frame 52 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of C1ORF52 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 2:234,853,378...234,860,045
Ensembl chr 2:234,853,410...234,860,040
|
|
G |
C4h12orf60 |
similar to human chromosome 12 open reading frame 60 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of C12ORF60 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 4:169,716,821...169,731,532
Ensembl chr 4:169,716,030...169,734,237
|
|
G |
C5 |
complement C5 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of C5 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 3:18,270,696...18,361,994
Ensembl chr 3:18,270,696...18,361,994
|
|
G |
C5h9orf152 |
similar to human chromosome 9 open reading frame 152 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of C9ORF152 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 5:72,660,573...72,667,941
Ensembl chr 5:72,660,573...72,668,379
|
|
G |
C7h12orf42 |
similar to human chromosome 12 open reading frame 42 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of C12ORF42 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 7:21,455,182...21,653,232
Ensembl chr 7:21,463,790...21,653,244
|
|
G |
C7h8orf33 |
similar to human chromosome 8 open reading frame 33 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of C8ORF33 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 7:108,682,122...108,684,372
Ensembl chr 7:108,682,176...108,684,358
|
|
G |
C8h3orf18 |
similar to human chromosome 3 open reading frame 18 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of C3ORF18 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 8:108,012,638...108,022,050
Ensembl chr 8:108,012,638...108,022,461
|
|
G |
C8h3orf62 |
similar to human chromosome 3 open reading frame 62 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of C3ORF62 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 8:109,080,032...109,084,588
Ensembl chr 8:109,036,030...109,097,895
|
|
G |
Cacna1a |
calcium voltage-gated channel subunit alpha1 A |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CACNA1A mRNA |
CTD |
PMID:37199045 |
|
NCBI chr19:23,520,741...23,819,971
Ensembl chr19:23,520,741...23,823,225
|
|
G |
Cacna1d |
calcium voltage-gated channel subunit alpha1 D |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CACNA1D mRNA |
CTD |
PMID:37199045 |
|
NCBI chr16:5,227,157...5,521,163
Ensembl chr16:5,228,306...5,668,215
|
|
G |
Cad |
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CAD mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 6:25,292,133...25,315,078
Ensembl chr 6:25,292,133...25,319,861
|
|
G |
Calb2 |
calbindin 2 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CALB2 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr19:38,114,435...38,141,438
Ensembl chr19:38,114,424...38,141,438
|
|
G |
Calhm6 |
calcium homeostasis modulator family member 6 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CALHM6 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr20:26,095,591...26,097,336
Ensembl chr20:26,095,592...26,097,278
|
|
G |
Calml3 |
calmodulin-like 3 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CALML3 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr17:66,419,844...66,423,083
Ensembl chr17:66,419,882...66,423,175
|
|
G |
Camkmt |
calmodulin-lysine N-methyltransferase |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CAMKMT mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 6:9,198,945...9,580,200
Ensembl chr 6:9,198,947...9,580,242
|
|
G |
Car12 |
carbonic anhydrase 12 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CA12 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 8:67,274,739...67,330,428
Ensembl chr 8:67,274,359...67,330,440
|
|
G |
Car6 |
carbonic anhydrase 6 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CA6 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 5:160,658,104...160,676,644
Ensembl chr 5:160,658,105...160,676,644
|
|
G |
Card19 |
caspase recruitment domain family, member 19 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CARD19 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr17:15,432,632...15,445,317
Ensembl chr17:15,432,612...15,445,318
|
|
G |
Carhsp1 |
calcium regulated heat stable protein 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CARHSP1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr10:6,946,036...6,960,556
Ensembl chr10:6,946,959...7,020,019
|
|
G |
Casp1 |
caspase 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CASP1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
|
|
G |
Casq2 |
calsequestrin 2 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CASQ2 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 2:189,526,003...189,582,276
Ensembl chr 2:189,525,960...189,582,267
|
|
G |
Cat |
catalase |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CAT mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cbr3 |
carbonyl reductase 3 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CBR3 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr11:33,008,615...33,016,877
Ensembl chr11:33,008,615...33,016,875
|
|
G |
Cc2d1a |
coiled-coil and C2 domain containing 1A |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CC2D1A mRNA |
CTD |
PMID:37199045 |
|
NCBI chr19:24,011,897...24,026,937
Ensembl chr19:24,011,938...24,026,936
|
|
G |
Ccdc13 |
coiled-coil domain containing 13 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CCDC13 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 8:121,455,202...121,507,487
Ensembl chr 8:121,457,697...121,502,337
|
|
G |
Ccdc136 |
coiled-coil domain containing 136 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CCDC136 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 4:57,997,825...58,027,598
Ensembl chr 4:57,997,853...58,027,646
|
|
G |
Ccdc172 |
coiled-coil domain containing 172 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CCDC172 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 1:257,629,188...257,682,373
Ensembl chr 1:257,629,208...257,675,247
|
|
G |
Ccdc191 |
coiled-coil domain containing 191 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CCDC191 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr11:56,735,655...56,806,372
Ensembl chr11:56,735,652...56,806,375
|
|
G |
Ccdc34 |
coiled-coil domain containing 34 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CCDC34 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 3:96,553,074...96,588,310
Ensembl chr 3:96,552,992...96,588,146
|
|
G |
Ccdc59 |
coiled-coil domain containing 59 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CCDC59 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 7:41,142,760...41,149,143
Ensembl chr 7:41,142,760...41,149,143
|
|
G |
Ccdc65 |
coiled-coil domain containing 65 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CCDC65 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 7:129,857,118...129,870,803
Ensembl chr 7:129,857,247...129,870,803
|
|
G |
Ccdc85a |
coiled-coil domain containing 85A |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CCDC85A mRNA |
CTD |
PMID:37199045 |
|
NCBI chr14:102,126,574...102,359,207
Ensembl chr14:102,129,029...102,359,058
|
|
G |
Ccdc96 |
coiled-coil domain containing 96 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CFAP184 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr14:74,276,568...74,279,072
Ensembl chr14:74,276,960...74,278,888
|
|
G |
Cchcr1 |
coiled-coil alpha-helical rod protein 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CCHCR1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr20:3,205,675...3,218,437
Ensembl chr20:3,205,676...3,218,308
|
|
G |
Ccm2 |
CCM2 scaffold protein |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CCM2 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr14:81,418,418...81,464,114
Ensembl chr14:81,418,236...81,464,116
|
|
G |
Ccna2 |
cyclin A2 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CCNA2 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
|
|
G |
Ccnb1 |
cyclin B1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CCNB1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Ccnb2 |
cyclin B2 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CCNB2 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 8:71,087,594...71,100,794
Ensembl chr 8:71,087,595...71,100,874
|
|
G |
Ccnd1 |
cyclin D1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CCND1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Ccne2 |
cyclin E2 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CCNE2 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 5:24,285,078...24,298,258
Ensembl chr 5:24,284,922...24,297,632
|
|
G |
Ccnj |
cyclin J |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CCNJ mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 1:239,659,588...239,677,367
|
|
G |
Ccr7 |
C-C motif chemokine receptor 7 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CCR7 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr10:84,098,193...84,108,309
Ensembl chr10:84,097,381...84,108,309
|
|
G |
Ccsap |
centriole, cilia and spindle-associated protein |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CCSAP mRNA |
CTD |
PMID:37199045 |
|
NCBI chr19:51,824,954...51,843,469
Ensembl chr19:51,826,994...51,842,753
|
|
G |
Cd19 |
CD19 molecule |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CD19 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 1:180,987,286...180,993,920
Ensembl chr 1:180,987,286...180,993,975
|
|
G |
Cd274 |
CD274 molecule |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CD274 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 1:227,116,674...227,137,379
Ensembl chr 1:227,116,649...227,134,450
|
|
G |
Cd40 |
CD40 molecule |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CD40 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
|
|
G |
Cd80 |
Cd80 molecule |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CD80 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr11:62,254,543...62,293,414
Ensembl chr11:62,254,624...62,292,030
|
|
G |
Cd82 |
Cd82 molecule |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CD82 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 3:79,387,361...79,431,847
Ensembl chr 3:79,385,887...79,431,809
|
|
G |
Cd83 |
CD83 molecule |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CD83 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr17:20,887,309...20,907,009
Ensembl chr17:20,887,309...20,907,083
|
|
G |
Cd8b |
CD8 subunit beta |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CD8B mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 4:103,312,596...103,328,523
Ensembl chr 4:103,312,578...103,328,553
|
|
G |
Cd9 |
CD9 molecule |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CD9 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 4:158,256,328...158,289,136
Ensembl chr 4:158,256,328...158,289,222
|
|
G |
Cd96 |
CD96 molecule |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CD96 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr11:54,702,290...54,776,618
Ensembl chr11:54,702,290...54,776,621
|
|
G |
Cdc20 |
cell division cycle 20 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CDC20 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 5:131,966,203...131,970,406
Ensembl chr 5:131,966,215...131,970,512
|
|
G |
Cdc25c |
cell division cycle 25C |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CDC25C mRNA |
CTD |
PMID:37199045 |
|
NCBI chr18:26,335,156...26,356,199
Ensembl chr18:26,335,834...26,356,185
|
|
G |
Cdc34 |
cell division cycle 34, ubiqiutin conjugating enzyme |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CDC34 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 7:10,017,588...10,023,586
Ensembl chr 7:10,017,588...10,023,186
|
|
G |
Cdc42ep4 |
CDC42 effector protein 4 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CDC42EP4 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr10:98,772,613...98,797,924
Ensembl chr10:98,772,495...98,797,695
|
|
G |
Cdc6 |
cell division cycle 6 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CDC6 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr10:83,864,189...83,878,011
Ensembl chr10:83,864,638...83,878,011
|
|
G |
Cdca2 |
cell division cycle associated 2 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CDCA2 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr15:41,895,946...41,942,226
Ensembl chr15:41,895,901...41,941,611
|
|
G |
Cdca5 |
cell division cycle associated 5 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CDCA5 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 1:203,378,550...203,392,027
Ensembl chr 1:203,378,577...203,392,023
|
|
G |
Cdca8 |
cell division cycle associated 8 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CDCA8 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 5:137,176,414...137,198,686
Ensembl chr 5:137,176,417...137,198,629
|
|
G |
Cdcp1 |
CUB domain containing protein 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CDCP1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 8:122,828,685...122,865,345
Ensembl chr 8:122,828,685...122,865,388
|
|
G |
Cdh10 |
cadherin 10 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CDH10 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 2:68,628,623...68,850,995
Ensembl chr 2:68,628,780...68,850,995
|
|
G |
Cdh19 |
cadherin 19 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CDH19 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr13:27,935,915...28,047,490
Ensembl chr13:27,936,668...28,019,310
|
|
G |
Cdh4 |
cadherin 4 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CDH4 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 3:166,525,092...167,003,380
Ensembl chr 3:166,525,099...167,003,371
|
|
G |
Cdhr5 |
cadherin-related family member 5 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CDHR5 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 1:196,373,110...196,381,609
Ensembl chr 1:196,373,112...196,381,543
|
|
G |
Cdk5rap2 |
CDK5 regulatory subunit associated protein 2 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CDK5RAP2 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 5:83,792,282...83,961,129
Ensembl chr 5:83,792,284...83,960,782
|
|
G |
Cdkn2aip |
CDKN2A interacting protein |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CDKN2AIP mRNA |
CTD |
PMID:37199045 |
|
NCBI chr16:44,536,147...44,546,216
Ensembl chr16:44,536,234...44,540,033
|
|
G |
Cdkn3 |
cyclin-dependent kinase inhibitor 3 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CDKN3 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr15:20,022,522...20,033,948
Ensembl chr15:20,022,664...20,033,945
|
|
G |
Cds1 |
CDP-diacylglycerol synthase 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CDS1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr14:7,820,328...7,882,943
Ensembl chr14:7,820,351...7,882,681
|
|
G |
Cdt1 |
chromatin licensing and DNA replication factor 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CDT1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr19:50,620,713...50,625,659
Ensembl chr19:50,620,713...50,625,659
|
|
G |
Cdx2 |
caudal type homeo box 2 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CDX2 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr12:7,726,798...7,733,142
Ensembl chr12:7,726,798...7,733,142
|
|
G |
Cel |
carboxyl ester lipase |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CEL mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 3:11,883,532...11,891,035
Ensembl chr 3:11,883,532...11,891,035
|
|
G |
Celf2 |
CUGBP, Elav-like family member 2 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CELF2 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr17:70,904,462...71,729,072
Ensembl chr17:71,210,853...71,728,333
|
|
G |
Cenpa |
centromere protein A |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CENPA mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 6:25,700,142...25,711,767
Ensembl chr 6:25,700,142...25,711,675
|
|
G |
Cenpf |
centromere protein F |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CENPF mRNA |
CTD |
PMID:37199045 |
|
NCBI chr13:101,184,127...101,229,714
Ensembl chr13:101,184,127...101,229,669
|
|
G |
Cenph |
centromere protein H |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CENPH mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 2:31,896,675...31,910,179
Ensembl chr 2:31,894,667...31,910,154
|
|
G |
Cenpj |
centromere protein J |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CENPJ mRNA |
CTD |
PMID:37199045 |
|
NCBI chr15:30,627,206...30,690,384
Ensembl chr15:30,627,224...30,686,791
|
|
G |
Cenpk |
centromere protein K |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CENPK mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 2:35,360,390...35,421,372
Ensembl chr 2:35,360,132...35,385,706
|
|
G |
Cenpl |
centromere protein L |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CENPL mRNA |
CTD |
PMID:37199045 |
|
NCBI chr13:73,337,235...73,352,115
Ensembl chr13:73,337,257...73,352,114
|
|
G |
Cep128 |
centrosomal protein 128 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CEP128 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 6:109,951,009...110,328,686
Ensembl chr 6:109,951,061...110,328,713
|
|
G |
Cep20 |
centrosomal protein 20 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CEP20 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr10:714,051...736,826
Ensembl chr10:714,151...736,837
|
|
G |
Cep43 |
centrosomal protein 43 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CEP43 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 1:52,533,418...52,564,025
Ensembl chr 1:52,533,428...52,563,923
|
|
G |
Cep55 |
centrosomal protein 55 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CEP55 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 1:235,832,823...235,848,401
Ensembl chr 1:235,832,878...235,848,394
|
|
G |
Cep76 |
centrosomal protein 76 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CEP76 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr18:61,174,514...61,208,512
Ensembl chr18:61,178,310...61,208,504
|
|
G |
Cep83 |
centrosomal protein 83 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CEP83 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 7:29,280,358...29,389,574
Ensembl chr 7:29,280,419...29,389,574
|
|
G |
Cep85l |
centrosomal protein 85-like |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CEP85L mRNA |
CTD |
PMID:37199045 |
|
NCBI chr20:32,568,417...32,739,449
Ensembl chr20:32,572,741...32,739,516
|
|
G |
Cep97 |
centrosomal protein 97 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CEP97 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr11:44,683,503...44,711,471
Ensembl chr11:44,683,506...44,711,471
|
|
G |
Cerkl |
ceramide kinase-like |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CERKL mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 3:64,238,714...64,344,695
Ensembl chr 3:64,237,522...64,340,675
|
|
G |
Cers3 |
ceramide synthase 3 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CERS3 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 1:120,316,930...120,422,926
Ensembl chr 1:120,318,212...120,422,902
|
|
G |
Cfap20dc |
CFAP20 domain containing |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CFAP20DC mRNA |
CTD |
PMID:37199045 |
|
NCBI chr15:16,231,248...16,476,978
Ensembl chr15:16,231,299...16,476,977
|
|
G |
Cfap210 |
cilia and flagella associated protein 210 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CFAP210 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 3:54,520,455...54,554,677
Ensembl chr 3:54,520,458...54,554,607
|
|
G |
Cfap43 |
cilia and flagella associated protein 43 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CFAP43 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 1:246,625,259...246,712,438
Ensembl chr 1:246,625,262...246,712,443
|
|
G |
Cfap46 |
cilia and flagella associated protein 46 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CFAP46 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 1:194,403,212...194,482,790
Ensembl chr 1:194,403,211...194,482,730
|
|
G |
Cfap54 |
cilia and flagella associated protein 54 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CFAP54 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 7:27,316,498...27,601,630
Ensembl chr 7:27,316,502...27,602,144
|
|
G |
Cfap91 |
cilia and flagella associated protein 91 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CFAP91 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr11:62,413,613...62,457,281
Ensembl chr11:62,413,602...62,457,293
|
|
G |
Cgas |
cyclic GMP-AMP synthase |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CGAS mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 8:79,292,282...79,306,998
Ensembl chr 8:79,294,511...79,305,496
|
|
G |
Cgref1 |
cell growth regulator with EF hand domain 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CGREF1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 6:25,431,846...25,443,853
Ensembl chr 6:25,431,799...25,443,852
|
|
G |
Chchd1 |
coiled-coil-helix-coiled-coil-helix domain containing 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CHCHD1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr15:3,592,719...3,593,901
Ensembl chr15:3,592,727...3,593,901
|
|
G |
Chic1 |
cysteine-rich hydrophobic domain 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CHIC1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr X:68,362,014...68,406,155
Ensembl chr X:68,361,969...68,437,887
|
|
G |
Chordc1 |
cysteine and histidine rich domain containing 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CHORDC1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 8:15,374,356...15,398,436
Ensembl chr 8:15,374,471...15,399,162
|
|
G |
Chrdl1 |
chordin-like 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CHRDL1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr X:106,889,125...106,992,937
Ensembl chr X:106,889,125...106,992,921
|
|
G |
Chrm3 |
cholinergic receptor, muscarinic 3 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CHRM3 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr17:60,005,137...60,467,250
Ensembl chr17:60,005,202...60,467,278
|
|
G |
Chst11 |
carbohydrate sulfotransferase 11 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CHST11 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 7:20,524,535...20,743,008
Ensembl chr 7:20,528,100...20,743,111
|
|
G |
Chst3 |
carbohydrate sulfotransferase 3 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CHST3 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr20:28,114,386...28,152,046
Ensembl chr20:28,114,404...28,121,807
|
|
G |
Chtop |
chromatin target of PRMT1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CHTOP mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 2:175,981,266...175,992,820
Ensembl chr 2:175,981,271...175,992,748
|
|
G |
Ciao3 |
cytosolic iron-sulfur assembly component 3 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CIAO3 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr10:14,795,888...14,804,953
Ensembl chr10:14,795,961...14,804,950
|
|
G |
Cib1 |
calcium and integrin binding 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CIB1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 1:134,178,331...134,183,895
Ensembl chr 1:134,178,331...134,213,423
|
|
G |
Cip2a |
cellular inhibitor of PP2A |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CIP2A mRNA |
CTD |
PMID:37199045 |
|
NCBI chr11:51,792,143...51,823,016
Ensembl chr11:51,795,024...51,822,938
|
|
G |
Ckap2 |
cytoskeleton associated protein 2 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CKAP2 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr16:69,839,668...69,864,852
Ensembl chr16:69,839,630...69,864,913
|
|
G |
Ckap2l |
cytoskeleton associated protein 2-like |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CKAP2L mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 3:116,497,186...116,524,302
Ensembl chr 3:116,498,022...116,524,366
|
|
G |
Cks1b |
CDC28 protein kinase regulatory subunit 1B |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CKS1B mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 2:174,833,025...174,837,614
Ensembl chr 2:174,833,050...174,837,636
|
|
G |
Cks2 |
CDC28 protein kinase regulatory subunit 2 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CKS2 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr17:13,570,611...13,575,770
|
|
G |
Clcf1 |
cardiotrophin-like cytokine factor 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CLCF1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 1:201,507,763...201,517,607
Ensembl chr 1:201,507,859...201,517,605
|
|
G |
Cldn1 |
claudin 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CLDN1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr11:74,421,569...74,436,728
Ensembl chr11:74,421,569...74,436,724
|
|
G |
Cldn11 |
claudin 11 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CLDN11 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 2:112,207,745...112,221,050
Ensembl chr 2:112,207,745...112,221,050
|
|
G |
Cldn12 |
claudin 12 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CLDN12 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 4:28,522,659...28,533,647
Ensembl chr 4:28,522,678...28,533,801
|
|
G |
Cldn2 |
claudin 2 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CLDN2 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr X:103,459,870...103,473,794
Ensembl chr X:103,459,780...103,474,838
|
|
G |
Clec12a |
C-type lectin domain family 12, member A |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CLEC12A mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 4:162,798,125...162,816,757
Ensembl chr 4:162,798,125...162,816,753
|
|
G |
Clec1b |
C-type lectin domain family 1, member B |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CLEC1B mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 4:162,847,978...162,856,291
Ensembl chr 4:162,848,010...162,856,291
|
|
G |
Clgn |
calmegin |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CLGN mRNA |
CTD |
PMID:37199045 |
|
NCBI chr19:24,695,140...24,728,542
Ensembl chr19:24,696,875...24,728,758
|
|
G |
Clic2 |
chloride intracellular channel 2 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CLIC2 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr20:149,337...164,375
Ensembl chr20:148,907...164,355
|
|
G |
Clic6 |
chloride intracellular channel 6 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CLIC6 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr11:31,737,813...31,780,360
Ensembl chr11:31,737,813...31,780,061
|
|
G |
Clk4 |
CDC-like kinase 4 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CLK4 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr10:35,523,382...35,541,387
Ensembl chr10:35,524,755...35,541,352
|
|
G |
Cln8 |
CLN8, transmembrane ER and ERGIC protein |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CLN8 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr16:74,749,662...74,759,553
Ensembl chr16:74,749,662...74,759,774
|
|
G |
Cluh |
clustered mitochondria homolog |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CLUH mRNA |
CTD |
PMID:37199045 |
|
NCBI chr10:59,509,580...59,531,345
Ensembl chr10:59,509,726...59,531,345
|
|
G |
Cnmd |
chondromodulin |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CNMD mRNA |
CTD |
PMID:37199045 |
|
NCBI chr15:55,041,548...55,066,297
Ensembl chr15:55,041,561...55,066,297
|
|
G |
Cnrip1 |
cannabinoid receptor interacting protein 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CNRIP1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr14:91,462,877...91,492,739
Ensembl chr14:91,462,647...91,492,735
|
|
G |
Cntn1 |
contactin 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CNTN1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 7:123,263,146...123,560,896
Ensembl chr 7:123,372,792...123,558,541
|
|
G |
Col10a1 |
collagen type X alpha 1 chain |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of COL10A1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr20:38,183,103...38,189,488
Ensembl chr20:38,182,494...38,189,494
|
|
G |
Col27a1 |
collagen type XXVII alpha 1 chain |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of COL27A1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 5:76,647,302...76,765,989
Ensembl chr 5:76,647,429...76,765,174
|
|
G |
Cpamd8 |
C3 and PZP-like, alpha-2-macroglobulin domain containing 8 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CPAMD8 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 4:155,332,827...155,413,098
Ensembl chr 4:155,332,827...155,413,117
|
|
G |
Cped1 |
cadherin-like and PC-esterase domain containing 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CPED1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 4:50,516,712...50,789,651
Ensembl chr 4:50,516,819...50,788,674
|
|
G |
Cplane1 |
ciliogenesis and planar polarity effector complex subunit 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CPLANE1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 2:57,269,195...57,369,580
Ensembl chr 2:57,268,884...57,369,500
|
|
G |
Cpne2 |
copine 2 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CPNE2 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr19:10,434,277...10,472,146
Ensembl chr19:10,434,277...10,471,820
|
|
G |
Cpt1a |
carnitine palmitoyltransferase 1A |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CPT1A mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 1:200,564,634...200,627,059
Ensembl chr 1:200,565,613...200,627,055
|
|
G |
Cracd |
capping protein inhibiting regulator of actin dynamics |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CRACD mRNA |
CTD |
PMID:37199045 |
|
NCBI chr14:31,284,066...31,520,103
Ensembl chr14:31,284,184...31,522,431
|
|
G |
Cracdl |
CRACD like |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CRACDL mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 9:39,834,321...39,950,763
Ensembl chr 9:39,834,833...39,951,086
|
|
G |
Cramp1 |
cramped chromatin regulator homolog 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CRAMP1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr10:13,983,781...14,032,409
Ensembl chr10:13,983,866...14,032,392
|
|
G |
Crebzf |
CREB/ATF bZIP transcription factor |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CREBZF mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 1:144,416,864...144,423,540
Ensembl chr 1:144,417,446...144,428,553
|
|
G |
Creld2 |
cysteine-rich with EGF-like domains 2 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CRELD2 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 7:119,909,626...119,916,556
Ensembl chr 7:119,909,633...119,916,543
|
|
G |
Crhbp |
corticotropin releasing hormone binding protein |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CRHBP mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 2:26,692,403...26,704,710
Ensembl chr 2:26,692,403...26,704,710
|
|
G |
Crkl |
CRK like proto-oncogene, adaptor protein |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CRKL mRNA |
CTD |
PMID:37199045 |
|
NCBI chr11:83,528,788...83,563,214
Ensembl chr11:83,526,530...83,563,238
|
|
G |
Crtac1 |
cartilage acidic protein 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CRTAC1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 1:241,091,679...241,233,677
Ensembl chr 1:241,078,864...241,233,421
|
|
G |
Crtam |
cytotoxic and regulatory T cell molecule |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CRTAM mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 8:41,340,117...41,377,381
Ensembl chr 8:41,340,837...41,377,343
|
|
G |
Cry2 |
cryptochrome circadian regulator 2 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CRY2 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 3:78,374,995...78,405,001
Ensembl chr 3:78,374,995...78,404,965
|
|
G |
Crybb1 |
crystallin, beta B1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CRYBB1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr12:44,369,734...44,383,344
Ensembl chr12:44,369,735...44,383,344
|
|
G |
Csmd2 |
CUB and Sushi multiple domains 2 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CSMD2 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 5:140,342,352...140,912,422
Ensembl chr 5:140,342,376...140,912,234
|
|
G |
Csn1s1 |
casein alpha s1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CSN1S1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr14:20,343,620...20,359,614
Ensembl chr14:20,343,619...20,359,614
|
|
G |
Ctps1 |
CTP synthase 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CTPS1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 5:134,125,022...134,154,155
Ensembl chr 5:134,125,025...134,154,180
|
|
G |
Ctsc |
cathepsin C |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CTSC mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 1:142,028,386...142,059,841
Ensembl chr 1:142,028,392...142,060,387
|
|
G |
Cxadr |
CXADR, Ig-like cell adhesion molecule |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CXADR mRNA |
CTD |
PMID:37199045 |
|
NCBI chr11:16,982,864...17,030,078
Ensembl chr11:16,982,860...17,030,046
|
|
G |
Cyb561 |
cytochrome b-561 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CYB561 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr10:90,878,052...90,888,734
Ensembl chr10:90,878,054...90,884,787
|
|
G |
Cylc2 |
cylicin 2 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CYLC2 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 5:65,554,320...65,576,251
Ensembl chr 5:65,554,309...65,589,282
|
|
G |
Cyp20a1 |
cytochrome P450, family 20, subfamily a, polypeptide 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CYP20A1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 9:61,755,804...61,805,123
Ensembl chr 9:61,755,790...61,805,123
|
|
G |
Cyp24a1 |
cytochrome P450, family 24, subfamily a, polypeptide 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CYP24A1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 3:159,275,947...159,290,383
Ensembl chr 3:159,275,947...159,290,383
|
|
G |
Cyp2f4 |
cytochrome P450, family 2, subfamily f, polypeptide 4 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CYP2F1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 1:82,416,107...82,429,897
Ensembl chr 1:82,416,130...82,429,896
|
|
G |
Cysltr2 |
cysteinyl leukotriene receptor 2 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of CYSLTR2 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr15:48,189,476...48,228,750
Ensembl chr15:48,189,073...48,304,136
|
|
G |
D430041D05Rikl |
RIKEN cDNA D430041D05 gene like |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of KIAA1549L mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 3:90,506,559...90,782,427
Ensembl chr 3:90,510,942...90,781,894
|
|
G |
Daxx |
death-domain associated protein |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of DAXX mRNA |
CTD |
PMID:37199045 |
|
NCBI chr20:4,970,090...4,976,145
Ensembl chr20:4,970,092...4,975,843
|
|
G |
Dcaf4 |
DDB1 and CUL4 associated factor 4 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of DCAF4 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 6:103,154,847...103,180,992
Ensembl chr 6:103,154,867...103,180,982
|
|
G |
Dct |
dopachrome tautomerase |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of DCT mRNA |
CTD |
PMID:37199045 |
|
NCBI chr15:95,062,006...95,100,863
Ensembl chr15:95,062,003...95,100,836
|
|
G |
Ddc |
dopa decarboxylase |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of DDC mRNA |
CTD |
PMID:37199045 |
|
NCBI chr14:86,378,685...86,469,189
Ensembl chr14:86,378,685...86,469,208
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of DDIT3 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Defb29 |
defensin beta 29 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of DEFB116 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 3:141,004,098...141,009,379
Ensembl chr 3:141,004,098...141,005,557
|
|
G |
Defb34 |
defensin beta 34 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of DEFB106A mRNA |
CTD |
PMID:37199045 |
|
NCBI chr16:70,720,200...70,723,134
Ensembl chr16:70,720,500...70,723,098
|
|
G |
Dennd11 |
DENN domain containing 11 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of DENND11 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 4:69,197,161...69,266,013
Ensembl chr 4:69,198,068...69,228,821
|
|
G |
Dennd2d |
DENN domain containing 2D |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of DENND2D mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 2:193,973,231...193,992,275
Ensembl chr 2:193,973,231...193,992,270
|
|
G |
Dennd4a |
DENN domain containing 4A |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of DENND4A mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 8:65,322,920...65,436,331
Ensembl chr 8:65,322,941...65,436,330
|
|
G |
Dennd4b |
DENN domain containing 4B |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of DENND4B mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 2:175,720,473...175,736,425
Ensembl chr 2:175,709,610...175,736,426
|
|
G |
Depdc1 |
DEP domain containing 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of DEPDC1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 2:248,684,508...248,717,951
Ensembl chr 2:248,684,523...248,717,951
|
|
G |
Desi1 |
desumoylating isopeptidase 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of DESI1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 7:113,519,974...113,542,834
Ensembl chr 7:113,519,980...113,542,845
|
|
G |
Dgki |
diacylglycerol kinase, iota |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of DGKI mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 4:65,410,878...65,872,733
Ensembl chr 4:65,420,108...65,872,733
|
|
G |
Dglucy |
D-glutamate cyclase |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of DGLUCY mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 6:120,055,480...120,130,910
Ensembl chr 6:120,055,460...120,130,910
|
|
G |
Dhx33 |
DEAH-box helicase 33 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of DHX33 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr10:55,708,102...55,724,618
Ensembl chr10:55,705,756...55,724,567
|
|
G |
Diaph1 |
diaphanous-related formin 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of DIAPH1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr18:29,669,659...29,769,070
Ensembl chr18:29,669,659...29,769,172
|
|
G |
Dio3 |
iodothyronine deiodinase 3 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of DIO3 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 6:129,285,747...129,287,608
Ensembl chr 6:129,285,749...129,286,660
|
|
G |
Diras3 |
DIRAS family GTPase 3 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of DIRAS3 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 6:130,524,972...130,526,186
Ensembl chr 6:130,524,742...130,530,825
|
|
G |
Dkk1 |
dickkopf WNT signaling pathway inhibitor 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of DKK1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 1:228,381,521...228,385,202
Ensembl chr 1:228,381,521...228,385,202
|
|
G |
Dlat |
dihydrolipoamide S-acetyltransferase |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of DLAT mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 8:50,979,151...51,004,435
Ensembl chr 8:50,978,051...51,004,479
|
|
G |
Dlgap5 |
DLG associated protein 5 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of DLGAP5 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr15:20,633,964...20,664,569
Ensembl chr15:20,633,966...20,664,518
|
|
G |
Dlx1 |
distal-less homeobox 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of DLX1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 3:56,356,190...56,360,780
Ensembl chr 3:56,356,190...56,360,780
|
|
G |
Dmc1 |
DNA meiotic recombinase 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of DMC1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 7:111,124,888...111,167,465
Ensembl chr 7:111,124,888...111,167,952
|
|
G |
Dmgdh |
dimethylglycine dehydrogenase |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of DMGDH mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 2:24,912,600...24,987,533
Ensembl chr 2:24,912,578...24,987,528
|
|
G |
Dnaaf5 |
dynein, axonemal, assembly factor 5 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of DNAAF5 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr12:15,453,636...15,492,722
Ensembl chr12:15,453,636...15,492,739
|
|
G |
Dnah5 |
dynein, axonemal, heavy chain 5 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of DNAH5 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 2:78,937,788...79,255,551
Ensembl chr 2:78,937,800...79,254,890
|
|
G |
Dnaja4 |
DnaJ heat shock protein family (Hsp40) member A4 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of DNAJA4 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 8:55,085,246...55,102,715
Ensembl chr 8:55,085,464...55,101,207
|
|
G |
Dnajb9 |
DnaJ heat shock protein family (Hsp40) member B9 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of DNAJB9 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 6:61,270,385...61,276,795
Ensembl chr 6:61,269,913...61,275,063
|
|
G |
Dnajc14 |
DnaJ heat shock protein family (Hsp40) member C14 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of DNAJC14 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 7:1,233,856...1,247,349
Ensembl chr 7:1,235,162...1,248,645
|
|
G |
Dnajc25 |
DnaJ heat shock protein family (Hsp40) member C25 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of DNAJC25 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 5:73,825,565...73,847,878
Ensembl chr 5:73,825,565...73,845,433
|
|
G |
Dnajc9 |
DnaJ heat shock protein family (Hsp40) member C9 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of DNAJC9 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr15:3,923,842...3,928,118
Ensembl chr15:3,923,268...3,928,118
|
|
G |
Dner |
delta/notch-like EGF repeat containing |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of DNER mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 9:85,586,985...85,902,461
Ensembl chr 9:85,586,987...85,902,637
|
|
G |
Dnm1l |
dynamin 1-like |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of DNM1L mRNA |
CTD |
PMID:37199045 |
|
NCBI chr11:84,581,216...84,632,382
Ensembl chr11:84,581,216...84,631,482
|
|
G |
Dnm2 |
dynamin 2 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of DNM2 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 8:19,978,313...20,060,162
Ensembl chr 8:19,978,400...20,060,157
|
|
G |
Dnmbp |
dynamin binding protein |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of DNMBP mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 1:242,736,189...242,829,431
Ensembl chr 1:242,736,189...242,802,604
|
|
G |
Dnmt3b |
DNA methyltransferase 3 beta |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of DNMT3B mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 3:142,130,588...142,169,128
Ensembl chr 3:142,130,592...142,169,124
|
|
G |
Doc2a |
double C2 domain alpha |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of DOC2A mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 1:181,457,415...181,462,528
Ensembl chr 1:181,458,390...181,462,030
|
|
G |
Dock10 |
dedicator of cytokinesis 10 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of DOCK10 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 9:81,843,599...82,101,540
Ensembl chr 9:81,843,604...82,101,525
|
|
G |
Dock9 |
dedicator of cytokinesis 9 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of DOCK9 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr15:98,611,518...98,883,306
Ensembl chr15:98,618,084...98,883,153
|
|
G |
Dohh |
deoxyhypusine hydroxylase |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of DOHH mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 7:8,321,466...8,326,305
Ensembl chr 7:8,321,466...8,326,289
|
|
G |
Dok7 |
docking protein 7 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of DOK7 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr14:75,665,444...75,699,413
Ensembl chr14:75,666,744...75,699,386
|
|
G |
Dpf3 |
double PHD fingers 3 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of DPF3 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 6:102,841,403...103,125,558
Ensembl chr 6:102,846,029...103,125,493
|
|
G |
Dpp10 |
dipeptidyl peptidase like 10 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of DPP10 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr13:34,584,420...36,269,292
Ensembl chr13:34,595,868...36,269,292
|
|
G |
Draxin |
dorsal inhibitory axon guidance protein |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of DRAXIN mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 5:158,530,149...158,563,457
Ensembl chr 5:158,530,342...158,564,483
|
|
G |
Drc12 |
dynein regulatory complex subunit 12 homolog |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of DRC12 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 8:44,576,528...44,584,345
Ensembl chr 8:44,577,836...44,584,338
|
|
G |
Drp2 |
dystrophin related protein 2 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of DRP2 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr X:97,607,577...97,658,117
Ensembl chr X:97,607,719...97,655,684
|
|
G |
Dscc1 |
DNA replication and sister chromatid cohesion 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of DSCC1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 7:86,482,588...86,498,212
Ensembl chr 7:86,482,588...86,498,212
|
|
G |
Dsp |
desmoplakin |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of DSP mRNA |
CTD |
PMID:37199045 |
|
NCBI chr17:26,623,602...26,671,692
Ensembl chr17:26,623,588...26,671,800
|
|
G |
Dtl |
denticleless E3 ubiquitin protein ligase homolog |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of DTL mRNA |
CTD |
PMID:37199045 |
|
NCBI chr13:103,115,810...103,155,029
Ensembl chr13:103,117,186...103,154,890
|
|
G |
Dtx4 |
deltex E3 ubiquitin ligase 4 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of DTX4 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 1:209,457,719...209,545,163
Ensembl chr 1:209,460,735...209,492,818
|
|
G |
Dus3l |
dihydrouridine synthase 3-like |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of DUS3L mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 9:1,593,491...1,598,663
Ensembl chr 9:1,594,123...1,598,655
|
|
G |
Dusp1 |
dual specificity phosphatase 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of DUSP1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr10:16,680,478...16,683,275
|
|
G |
Dusp10 |
dual specificity phosphatase 10 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of DUSP10 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr13:95,613,716...95,651,716
Ensembl chr13:95,614,292...95,651,716
|
|
G |
Dusp16 |
dual specificity phosphatase 16 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of DUSP16 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 4:167,546,780...167,630,173
Ensembl chr 4:167,548,155...167,629,980
|
|
G |
Dusp26 |
dual specificity phosphatase 26 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of DUSP26 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr16:61,041,784...61,049,319
Ensembl chr16:61,041,792...61,049,051
|
|
G |
Dusp5 |
dual specificity phosphatase 5 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of DUSP5 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 1:252,538,408...252,555,320
Ensembl chr 1:252,538,449...252,551,818
|
|
G |
Dusp6 |
dual specificity phosphatase 6 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of DUSP6 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 7:34,092,848...34,097,186
Ensembl chr 7:34,092,943...34,097,185
|
|
G |
Dusp7 |
dual specificity phosphatase 7 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of DUSP7 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 8:107,009,369...107,016,404
Ensembl chr 8:107,008,528...107,016,404
|
|
G |
Dync1h1 |
dynein cytoplasmic 1 heavy chain 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of DYNC1H1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 6:129,615,208...129,680,888
Ensembl chr 6:129,609,397...129,680,883
|
|
G |
Dyrk3 |
dual specificity tyrosine phosphorylation regulated kinase 3 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of DYRK3 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr13:42,594,120...42,604,898
Ensembl chr13:42,594,121...42,604,778
|
|
G |
E2f3 |
E2F transcription factor 3 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of E2F3 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr17:34,601,756...34,679,139
Ensembl chr17:34,601,830...34,676,253
|
|
G |
E2f7 |
E2F transcription factor 7 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of E2F7 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 7:46,150,533...46,192,739
Ensembl chr 7:46,151,293...46,192,734
|
|
G |
E2f8 |
E2F transcription factor 8 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of E2F8 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 1:98,565,717...98,584,265
Ensembl chr 1:98,565,717...98,584,098
|
|
G |
Eaf2 |
ELL associated factor 2 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of EAF2 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr11:63,960,200...64,004,610
Ensembl chr11:63,960,200...64,004,610
|
|
G |
Ebf1 |
EBF transcription factor 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of EBF1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr10:29,095,858...29,489,142
Ensembl chr10:29,099,933...29,487,665
|
|
G |
Echdc1 |
ethylmalonyl-CoA decarboxylase 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ECHDC1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 1:28,476,354...28,507,173
Ensembl chr 1:28,476,200...28,507,319
|
|
G |
Ecm1 |
extracellular matrix protein 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ECM1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 2:183,287,491...183,292,729
Ensembl chr 2:183,287,322...183,292,671
|
|
G |
Ecpas |
Ecm29 proteasome adaptor and scaffold |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ECPAS mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 5:73,601,745...73,714,026
Ensembl chr 5:73,604,533...73,713,860
|
|
G |
Ect2 |
epithelial cell transforming 2 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ECT2 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 2:109,975,813...110,037,911
Ensembl chr 2:109,975,813...110,037,911
|
|
G |
Edc4 |
enhancer of mRNA decapping 4 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of EDC4 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr19:33,774,062...33,786,054
Ensembl chr19:33,774,055...33,787,758
|
|
G |
Edem1 |
ER degradation enhancing alpha-mannosidase like protein 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of EDEM1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 4:141,797,631...141,829,717
Ensembl chr 4:141,797,701...141,829,717
|
|
G |
Ednrb |
endothelin receptor type B |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of EDNRB mRNA |
CTD |
PMID:37199045 |
|
NCBI chr15:80,640,839...80,672,115
Ensembl chr15:80,643,043...80,672,115
|
|
G |
Edrf1 |
erythroid differentiation regulatory factor 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of EDRF1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 1:188,441,514...188,478,743
Ensembl chr 1:188,441,634...188,478,701
|
|
G |
Eeig2 |
EEIG family member 2 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of EEIG2 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 2:196,608,499...196,663,371
Ensembl chr 2:196,608,499...196,663,371
|
|
G |
Efna2 |
ephrin A2 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of EFNA2 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 7:9,515,635...9,528,071
Ensembl chr 7:9,516,429...9,527,061
|
|
G |
Eif1ad |
eukaryotic translation initiation factor 1A domain containing |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of EIF1AD mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 1:202,674,362...202,679,662
Ensembl chr 1:202,674,185...202,679,658
|
|
G |
Eif2s2 |
eukaryotic translation initiation factor 2 subunit beta |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of EIF2S2 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 3:143,374,652...143,395,460
Ensembl chr 3:143,373,686...143,395,432
|
|
G |
Eif4g1 |
eukaryotic translation initiation factor 4 gamma 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of EIF4G1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr11:80,221,919...80,241,958
Ensembl chr11:80,221,919...80,241,941
|
|
G |
Elk3 |
ETS transcription factor ELK3 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ELK3 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 7:27,768,582...27,831,088
Ensembl chr 7:27,768,599...27,804,084
|
|
G |
Elmod3 |
ELMO domain containing 3 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ELMOD3 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 4:104,614,665...104,653,122
Ensembl chr 4:104,614,676...104,653,053
|
|
G |
Emb |
embigin |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of EMB mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 2:49,070,509...49,125,042
Ensembl chr 2:49,069,087...49,125,050
|
|
G |
Emc8 |
ER membrane protein complex subunit 8 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of EMC8 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr19:48,708,304...48,721,626
Ensembl chr19:48,582,574...48,721,543
|
|
G |
Eml1 |
EMAP like 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of EML1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 6:127,283,968...127,457,246
Ensembl chr 6:127,284,029...127,457,246
|
|
G |
Emp1 |
epithelial membrane protein 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of EMP1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 4:168,212,901...168,233,039
Ensembl chr 4:168,212,861...168,232,904
|
|
G |
Eno4 |
enolase 4 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ENO4 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 1:258,096,406...258,119,811
Ensembl chr 1:258,096,432...258,128,984
|
|
G |
Enox1 |
ecto-NOX disulfide-thiol exchanger 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ENOX1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr15:52,517,833...53,079,752
Ensembl chr15:52,515,178...53,079,749
|
|
G |
Enpp1 |
ectonucleotide pyrophosphatase/phosphodiesterase 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ENPP1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 1:20,698,746...20,763,741
Ensembl chr 1:20,698,764...20,763,715
|
|
G |
Epas1 |
endothelial PAS domain protein 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of EPAS1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 6:7,790,236...7,871,717
Ensembl chr 6:7,790,647...7,871,228
|
|
G |
Epn3 |
epsin 3 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of EPN3 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr10:79,438,978...79,449,516
Ensembl chr10:79,438,978...79,447,356
|
|
G |
Epo |
erythropoietin |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of EPO mRNA |
CTD |
PMID:37199045 |
|
NCBI chr12:19,204,258...19,207,948
Ensembl chr12:19,204,508...19,207,946
|
|
G |
Eps15l1 |
epidermal growth factor receptor pathway substrate 15-like 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of EPS15L1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr16:17,426,345...17,501,677
Ensembl chr16:17,426,421...17,501,677
|
|
G |
Erich1 |
glutamate-rich 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ERICH1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr16:75,501,322...75,569,129
Ensembl chr16:75,501,384...75,569,128
|
|
G |
Ero1a |
endoplasmic reticulum oxidoreductase 1 alpha |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ERO1A mRNA |
CTD |
PMID:37199045 |
|
NCBI chr15:18,495,037...18,530,440
Ensembl chr15:18,492,945...18,530,478
|
|
G |
Ero1b |
endoplasmic reticulum oxidoreductase 1 beta |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ERO1B mRNA |
CTD |
PMID:37199045 |
|
NCBI chr17:85,861,086...86,003,244
Ensembl chr17:85,929,618...86,003,398
|
|
G |
Esco1 |
establishment of sister chromatid cohesion N-acetyltransferase 1 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ESCO1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr18:1,630,560...1,686,803
Ensembl chr18:1,631,954...1,686,942
|
|
G |
Espnl |
espin-like |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ESPNL mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 9:91,912,038...91,936,803
Ensembl chr 9:91,912,049...91,935,292
|
|
G |
Etfdh |
electron transfer flavoprotein dehydrogenase |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ETFDH mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 2:164,740,547...164,762,754
Ensembl chr 2:164,729,749...164,762,745
|
|
G |
Ethe1 |
ETHE1, persulfide dioxygenase |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ETHE1 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 1:80,184,037...80,199,092
Ensembl chr 1:80,183,894...80,199,052
|
|
G |
Etv3 |
ETS variant transcription factor 3 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ETV3 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr 2:172,965,461...172,980,320
Ensembl chr 2:172,965,588...172,980,314
|
|
G |
Etv4 |
ETS variant transcription factor 4 |
increases expression |
ISO |
2-palmitoylglycerol results in increased expression of ETV4 mRNA |
CTD |
PMID:37199045 |
|
NCBI chr10:86,706,749...86,721,974
Ensembl chr10:86,706,749...86,721,974
|
|
G |
|